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Abstract 
The sensory hair bundles of the cochlea are complex structures that are vital for hearing. 
Phosphorylation plays an important role in regulating actin in many cell types, but the 
role it plays in regulating the development and maintenance of the hair bundle has yet to 
be fully elucidated. Furthermore, the extent to which damaged hair bundles can be 
repaired in the mammalian cochlea remains to be determined. The aims of this study 
were twofold: 1) to assess the role of phosphorylation in hair bundle development and 
2) to ascertain whether hair bundles could recover from any damage caused by protein 
kinase inhibition or the aminoglycoside neomycin. Post-natal mouse cochlear cultures 
were treated with a range of protein kinase inhibitors. Of those tested, the broad-
spectrum protein kinase inhibitor staurosporine was found to cause hair bundle collapse 
and detachment of the apical cell membrane from the cuticular plate without causing 
cell death. Further investigation suggests that staurosporine may have its effects through 
inhibiting the function of the Ezrin-Radixin-Moesin proteins, an important family of 
proteins that cross link actin to the plasma membrane. An inhibitor of c-Jun NH2-
terminal kinase, JNK inhibitor I, was also found to cause the loss of hair bundles, but in 
contrast to staurosporine, also caused hair cell death. This was unexpected, as previous 
studies have shown that inhibition of c-Jun NH2-terminal kinase confers protection on 
hair cells from noise and aminoglycoside damage. Recovery of hair bundles was not 
observed following brief treatment with either staurosporine or neomycin. The current 
study shows that protein phosphorylation is vital for the proper maintenance of the hair 
bundle, and hair that bundles show little sign of recovery from limited damage in vitro. 
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1.1 The inner ear and its sensory organs 
The mammalian inner ear provides the sensory perceptions of balance and hearing. It 
consists of six sensory organs: the maculae, comprising of the utricle and saccule which 
detect gravity in the horizontal and vertical planes, the three cristae of the semicircular 
canals, which detect angular head movement, and the organ of Corti, which is 
responsible for hearing (Figure 1.1). All six of these organs are formed from an ordered 
arrangement of sensory hair cells and their non-sensory supporting cells which reside on 
a basal lamina. As the supporting cells surround the hair cells, hair cells are effectively 
isolated from each other as well as the basal lamina. Overlying the hair cells are 
different extracellular matrices depending on the sensory organ: the otolithic membrane 
in the maculae, the gelatinous cupula in the cristae and the tectorial membrane of the 
cochlea (Figure 1.2). 
 
 
Figure 1.1 The six sensory organs of the mammalian inner ear (adapted from Purves et al, 
2007). 
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Figure 1.2 Inner ear extracellular matrices: otolithic membrane of the maculae (A), gelatinous 
cupula of the cristae (B) and the tectorial membrane of the cochlea (C). Panel A and B adapted 
from Purves et al (2007), panel C adapted from “Index of//Fisiologia/neurofisiologia/Objetivo 
_4/Clayman89c.jpeg”. 
 
1.2 Hair cell function 
The sensory hair cells on which the functions of the inner ear are based are polarised 
epithelial cells that possess a tuft of stereocilia (the hair bundle) on their apical surfaces. 
It is this tuft that gives the hair cells their name, and within the inner ear, movement of 
 21 
the hair cell relative to its overlying matrix causes hair bundle deflection. Deflection 
away from the tallest part of the hair bundle results in hyper-polarisation of the hair cell, 
but deflection towards the tallest part of the hair bundle leads to an influx of potassium 
ions into the hair cells via the mechanotransduction channels situated at the tips of all 
but the tallest stereocilia (Beurg et al, 2009). This leads to hair cell depolarisation and 
neurotransmitter release from the basal pole of the cell (Figure 1.3) with subsequent 
excitation of the primary afferent nerve connected to the hair cell (Khan et al, 1982). 
The neurotransmitter used by hair cells is thought to be glutamate (Cochran and 
Correia, 1995: Kataoka and Ohmori, 1996: Glowatzki et al, 2006).  
 
 
Figure 1.3 Hair bundle movement leading to hair cell hyperpolarisation and depolarisation 
(adapted from Purves et al, 2007). 
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1.3 The hair bundle 
The stereocilia that make up the hair bundle are rigid, actin-filled protrusions which are 
arranged in rows in a height dependent manner (Figure 1.4 A, B, C). Within the organ 
of Corti, this height dependent arrangement of the stereocilia is extremely regular, 
resulting in the distinctive staircase morphology of hair bundles in the inner hair cells 
(IHCs) and outer hair cells (OHCs) (Furness et al, 1989) (Figure 1.4 B, C). The shape of 
the IHC and OHC hair bundles also differ, with the IHC hair bundles tending towards a 
wide shallow “W” shape and comprising of approximately three rows of stereocilia, 
while OHC hair bundles have a “V” shape and have approximately three to five rows of 
stereocilia (Furness et al, 1989: Shim, 2006) (Figure 1.4 B, C). The exact shape, height 
and number of stereocilia in an inner or outer hair cell hair bundle also depend on its 
location along the organ of Corti, of the three rows of OHCs on the basilar membrane, 
hair bundles on the most laterally located OHCs (third row) are taller than those situated 
on the more medially located first row, while stereocilia at the high frequency basal end 
of the cochlea are shorter, have a greater diameter and are more numerous than those at 
the low frequency apical end (Lim, 1980: Tilney and Saunders, 1983). Regardless of 
their location, both inner and outer hair cell bundles are strictly orientated with the 
tallest stereocilia lying on the opposite side to the modiolus (Tilney et al, 1986). 
In order for the entire hair bundle to move as a single unit in response to mechanical 
stimulation, each stereocilium within the hair bundle is connected to its immediate 
neighbours within its row, as well as to the taller and shorter stereocilia in front or 
behind it, by filamentous links (Osborne et al, 1984: Pickles et al, 1984: Takumida, 
2001). These links are highly organised, and occur in specific locations along the 
stereocilia. In the mouse cochlea, a mature collection of different link types consisting 
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of tectorial membrane attachment crowns, tip links, and horizontal top connectors is 
present by postnatal day 19 (P19) on OHC hair bundles (Goodyear et al, 2005). 
 
 
Figure 1.4 Hair bundles of the inner ear: vestibular hair bundles (A), IHC hair bundle (B) and 
OHC hair bundle (C) (adapted from Wellcome Images: B0006268, B0004625 and B0000111). 
 
1.3.1 Attachment crowns, tip links, and horizontal top connectors 
At the top of the tallest row of OHC stereocilia are the tectorial membrane attachment 
crowns, which consist of a number of particles attached by filaments to the top of the 
stereocilium (Tsuprun and Santi, 1998: Goodyear et al, 2005) (Figure 1.5). 
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Tip links connect the tip of shorter stereocilia to the side of taller stereocilia in the next 
row (Figure 1.5) (Osborne et al, 1984: Comis et al, 1985). This particular type of link 
has generated much interest due to the possibility that it can gate the opening and 
closing of the mechanotransduction channel. Indeed, experimental removal of tip links 
abolished transducer currents (Assad et al, 1991: Preyer et al, 1995), although whether 
the tip link gates the mechanotransducer channel directly or as part of another 
mechanism is unknown (Meyer et al, 1998: Meyer et al, 2005). Currently, tip links are 
known to comprise of two members of the cadherin superfamily of cell adhesion 
molecules, cadherin 23 (CDH23) and protocadherin 15 (PCDH15) (Siemens et al, 2004: 
Söllner et al, 2004: Ahmed et al, 2006: Kazmierczak et al, 2007), both of which contain 
a transmembrane domain and a C-terminal cytoplasmic domain (El-Amraoui and Petit, 
2005). However, they differ from classical cadherins by containing many more 
ectodomain repeats, up to 11 in PCDH15 (Ahmed et al, 2006: Ahmed et al, 2008) and 
27 in CDH23 (Di Palma et al, 2001). 
Below the tip links are the horizontal top connectors that link stereocilia both intra- and 
inter-row (Tsuprun and Santi, 2002: Verpy et al, 2008) (Figure 1.5). Horizontal top 
connectors consist of the protein stereocilin. At the onset of audition in mice at 
approximately P14, stereocilin-null mice show no horizontal top connectors, but 
demonstrate normal hearing. These mice however, go on to show progressive hearing 
loss (Verpy et al, 2008). 
 
1.3.2 Transient links: ankle link, shaft connectors and kinocilial links 
Before hair bundle links reach their mature complement, other transient link types exist 
(Goodyear et al, 2005). The kinocilium of the mammalian hair bundle degenerates as 
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the hair bundle matures. During development however, kinocilial links connect the 
kinocilium to the tallest stereocilia (Müller, 2008) (Figure 1.5). 
 
 
Figure 1.5 OHC hair bundle links in the mouse at postnatal day 2 (P2) and postnatal day 19 
(P19) (courtesy of Dr RJ Goodyear). 
 
The kinocilial links may comprise of the proteins that form tip links: CDH23 and 
PCDH15 (Michel et al, 2005: Ahmed et al, 2006). Transient stereocilia shaft connectors 
consisting of protein tyrosine phosphatase receptor Q (Ptprq) are important for the 
maturation of hair bundles, and the absence of Ptprq during development results in hair 
bundle disorganisation and hair cell loss (Goodyear et al, 2003: Sakaguchi et al, 2008). 
Ankle links appear transiently at the base of mice hair bundles at approximately P2 and 
disappear by P12 (Goodyear et al, 2005). Despite its brief existence, the ankle link 
complex, comprising of the very large G-protein-coupled receptor 1 (Vlgr1), the 
transmembrane proteins usherin and vezatin, as well as the triple PDZ (postsynaptic 
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density 95, PSD-95; discs large, Dlg; zonula occludens-1, ZO-1) domain-containing 
submembrane protein whirlin, plays an important part in the organizational integrity of 
the hair bundle. Where the formation of ankle links has been compromised as in Vlgr1-/- 
mice, there is hair bundle disorganisation and mechanotransduction impairment 
resulting in early postnatal hearing loss and eventual hair cell loss (Adato et al, 2005: 
McGee et al, 2006). 
 
1.3.3 Actin-bundling proteins within the stereocilia 
Each individual stereocilium of the hair bundle consists of densely packed, highly cross-
linked and highly organised actin filaments (F-actin) (Flock and Cheung, 1977: Tilney 
et al, 1980), which are polarised such that their plus ends (site of net polymerisation) are 
situated at the tip of the stereocilium, while their minus ends (site of net de-
polymerisation) are positioned at the base of the stereocilium (Tilney et al, 1992a). 
These F-actin filaments are cross-linked by two proteins, espin and fimbrin (I-plastin). 
Espin is a ~ 110 kDa actin binding protein, with F-actin binding sites at both the N-
terminus and C-terminus (Chen et al, 1999). There are 4 known espin isoforms that 
arise from different transcription sites of the same gene (Sekerková, 2004), and all 4 
isoforms contain the 116-amino acid C-terminal actin-bundling module, as well as the 
actin-monomer-binding WASP homology 2 (WH2) domain (Bartles et al, 1996: Loomis 
et al, 2003: Sekerková, 2006b). Espin 1 to 3 also contain proline rich regions, while 
Espin 1 and 2 have additional F-actin binding sites. Espin 1 also has multiple ankyrin-
like repeats (Sekerková, 2006b). 
In rats, espin can be detected in immature hair bundles as soon as the hair bundle 
appears on hair cells at around E16 (Sekerková, 2006a), rat espin 1 is restricted to the 
vestibular hair cells, while espin 2 is expressed during development but levels decrease 
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before birth. Espin 3 is transiently expressed during development, and espin 4 remains 
present in mature hair bundles (Sekerková, 2006a). In addition to their role as highly 
efficient actin bundling proteins (Chen et al, 1999), espins may have a role in the 
regulation of stereocilia height, before their eventual degeneration, OHC stereocilia of 
espin null mice (jerker mice) show both reduced height and width, and the vestibular 
stereocilia of jerker mice also show shortening in comparison to heterozygous controls 
(Zheng et al, 2000: Rzadzinska et al, 2005). Further support for the role of espin in 
stereocilia height regulation stems from a recent study showing over-expression of espin 
1 and myosin IIIa in rat hair cells causes stereocilia elongation compared to over-
expression of either espin 1 or myosin IIIa alone (Salles et al, 2009). It is thought that 
the WH2 domain of espin 1 interacts with the plus-end-directed motor myosin IIIa, 
resulting in the transportation of espin 1 to the tips of stereocilia in rat hair cells (Salles 
et al, 2009). In humans, a novel espin mutation has recently been identified, resulting in 
the loss of both the WH2 and the C-terminal actin binding domains and causing severe 
to profound hearing loss with no apparent vestibular dysfunction (Boulouiz et al, 2008). 
 
Fimbrin is a ~ 64 kDa actin bundling protein, with two EF-hands at the N-terminal and 
two actin binding domains (ABD1, ABD 2), each divided into two calponin homology 
(CH) domains (Delanote et al, 2005). There are 3 isoforms of fimbrin/plastin: I, T and 
L, with the I and T isoforms expressed in stereocilia (Shepherd et al, 1989: de Arruda et 
al, 1990: Drenckhahn et al, 1991). I-plastin is present in rat IHCs from at least 
embryonic day 18, and is present in the adult hair bundle (Zine et al, 1995). In contrast, 
the levels of T-plastin peak at P7 in rat stereocilia, but T-plastin is not detectable at all 
in hair cell stereocilia by P60 (Daudet and Lebart, 2002).  
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As a result of the tight packing and cross-linking of F-actin by espin and fimbrin, under 
normal physiological conditions a stereocilium is stiff, and does not tend to bend along 
its length. 
 
1.3.4 Anchoring the stereocilia: rootlets and the cuticular plate 
The rigidity of the stereocilia means that the deflection of the hair bundle during 
mechanical stimulation occurs at the ankle of the stereocilia, where the F-actin enters 
the hair cell as the rootlet (Flock and Cheung, 1977: Slepecky and Chamberlain, 1982). 
Due to the tapering that occurs at the stereocilium ankle, only a small number of the 
total actin filaments that are present in the stereocilium make up the rootlet (Itoh, 1982). 
The rootlet itself can be seen as an electron dense column that starts two-thirds of the 
way down within the stereocilia, becoming wider as it nears the apical surface of the 
cell, then extending into and anchoring itself within the cuticular plate of the hair cell 
(Figure 1.6) (Furness et al, 2008). Inside the hair cell, numerous fibrils extend from the 
rootlet and are attached to the network of actin filaments that makes up the cuticular 
plate (Itoh, 1982: Arima et al, 1987). Rootlets damaged either by experimental means 
such as a water jet, or by noise, can contribute to the loss of cochlear sensitivity even 
where there is no obvious hair bundle injury (Liberman and Dodds, 1987: Duncan and 
Saunders, 2000). 
Within the cuticular plate, the randomly orientated actin filaments form a gel-like mesh 
due to linkage by spectrin (alpha-fodrin) (Demêmes and Scarfone, 1992: 
Mahendrasingam, 1998), a protein that exists as an α- (molecular mass 240 kDa) and β- 
(220 kDa) heterotetramer (Chakrabarti et al, 2006: Prasain and Stevens, 2009). In 
addition to being localised in the cuticular plate, the αII-βV spectrin isoform has also 
been localised to the cortical lattice of the OHC, where it contributes to OHC motility 
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by providing structural integrity (Legendre et al, 2008). Other constituents of the 
cuticular plate have not been unequivocally agreed upon: different studies have shown 
either tropomyosin or α-actinin are present or absent, or present but in different 
locations within the cuticular plate (Sans et al, 1989: Slepecky and Chamberlain, 1985: 
Drenckhahn et al, 1991: Furness et al, 2008). 
 
    
Figure 1.6 Transverse section through three rows of stereocilia showing rootlets, with arrows 
indicating the beginning of the rootlet (adapted from Fettiplace and Hackney, 2006). 
 
1.3.5 Actin treadmilling within the stereocilia 
A distinctive feature of mammalian hair bundles is that they are intended to function 
over the entire lifespan of the organism (Corwin, 1992), and as a consequence, 
stereocilia of the hair bundle have been viewed as extremely stable structures. Yet like 
F-actin in the cell cytoplasm, the F-actin cores of stereocilia have been shown to 
undergo “head-to-tail polymerisation” (treadmilling) (Schneider et al, 2002: Rzadzinska 
et al, 2004), where the rate of actin polymerisation at the plus end equals the rate of 
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depolymerisation at the minus end, resulting in a filament of constant length (Figure 
1.7) (Wegner, 1976: Neuhaus et al, 1983). 
The rate of treadmilling in each individual stereocilium is dependent upon its height, the 
taller the stereocilia, the faster the treadmilling (Rzadzinska et al, 2004). Hence in the 
mature rat hair bundle, actin monomers are polymerised at the plus end of the filaments, 
along with espin, and over a 48-hour period, the entire bundle is turned over as one unit 
(Schneider et al, 2002: Rzadzinska et al, 2004).  
 
    
Figure 1.7 Actin molecular treadmill model (adapted from Lin et al, 2005). 
 
1.4 Hair bundle development  
1.4.1 Chick hair bundle development 
Much of the work on the highly coordinated and organised development of the hair 
bundle has been carried out in chicks, where hair cells can be first distinguished from 
supporting cells at embryonic day 6 (E6) by the concentric arrangement of the 
microvilli on their apical surfaces (Cotanche, 1987a). A single microtubular kinocilium 
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is also present at the centre of hair cells, but between E9-11, this will have moved so 
that the kinocilium of each developing hair bundle is roughly in the same peripheral 
area of the circular hair bundle (Tilney et al 1992b). Over this same time period, the 
hitherto variable widths of the stereocilia become more standardised, possibly due to 
cross-linking by actin-bundling proteins such as espin (Li et al, 2004).  
Formation of the characteristic hair bundle staircase begins from E10-12 by sequential 
elongation, where the row of stereocilia nearest the kinocilium begins to elongate first, 
followed by the next row and so on (Tilney et al, 1988). As a row of stereocilia becomes 
incorporated into the staircase, tip links appear, and transducer currents can be detected 
from E11 (Tilney et al, 1992a: Si et al, 2003). The circular shape of the hair bundle also 
changes as the side with the tallest stereocilia straightens out, creating a semi-circle 
(Tilney et al 1992b), and the final rectangular shape of the chick hair bundle is 
eventually achieved by the reabsorbing of superfluous stereocilia (Tilney et al, 1992b). 
From E13-16, the hair bundle temporarily pauses elongation to increase the diameters of 
the stereocilia by incorporating new actin filaments onto the cross-linked “cores” 
(Tilney and DeRosier, 1986), and the number of filaments added can be high, increasing 
from 100 filaments at E11 to 400 at E16 (Tilney and DeRosier, 1986). Although the 
height of the hair bundle is not increasing at this time, stereocilia are in fact extending 
downwards into the developing cuticular plate by way of newly formed rootlets 
(Cotanche, 1987a). The tapered morphology of mature stereocilia also develops at this 
time as the base of the stereocilia becomes pinched in (Tilney and DeRosier, 1986). 
From E17, elongation of the entire hair bundle recommences until the mature height is 
reached, but this stage is also used to reinforce the staircase pattern, with the shortest 
row completing elongation first and the tallest row completing last (Tilney et al, 1986). 
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1.4.2 Mammalian hair bundle development 
A similar process of hair bundle development has been reported in mammals, although 
there does not appear to be the temporal separation of stereocilia thickening and 
elongation (Zine and Romand, 1996: Mu et al, 1997: Forge, 1997). In addition, the hair 
bundle staircase morphology that is generated in the chick by the sequential elongation 
of stereocilia, in mammalian hair bundles, may be the result of different stereocilia 
growth rates (Kaltenbach et al, 1994).  
For both chick and mammals, the hair bundle development process is highly organised 
and must necessarily involve the close regulation of actin polymerisation, 
depolymerisation, and cross-linking, although very little is known about how these 
processes are regulated. Certain aspects are gradually being elucidated however, actin 
treadmilling within stereocilia has been proposed to provide a method of transporting 
cargo such as myosins and other proteins to the appropriate sites along the stereocilia 
(Naoz et al, 2008). Currently though, most of what is known about hair bundle 
development and actin regulation within the stereocilia stems from studying proteins 
directly associated with the stereocilia, as mutations in these proteins causes hair bundle 
defects and many of these proteins derive from known deafness loci. 
 
1.4.3 Usher’s syndrome 
Mutations of the proteins that cause hair bundle defects are often, but not exclusively, 
associated with Usher’s syndrome, the most common form of deaf-blindness, caused by 
progressive retinal degeneration (retinitis pigmentosa) coupled with varying degrees of 
hearing loss (Kloepfer et al, 1966: Fishman et al, 1979: Rosenberg et al, 1997: Spandau 
and Rohrschneider, 2002). Mutations in Usher’s syndrome genes can also result in non-
syndromic hearing loss (Saihan et al, 2009).  
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Clinically, Usher’s syndrome is categorised into 3 types: Usher type 1 is characterized 
by severe to profound congenital sensorineural loss and continuous balance deficiency 
(vestibular dysfunction). Hearing loss in Usher type 2 varies from mild to severe, with 
no vestibular dysfunction, while Usher type 3 shows progressive hearing loss and 
variable vestibular dysfunction. All 3 types present with retinitis pigmentosa and 
possible cataract (Petit, 2001: Williams, 2008). Table 1.1 summarises the Usher’s 
syndrome loci and their affected proteins (Gibson et al, 1995: Weil et al, 1995: Verpy et 
al, 2000: Alagramam et al, 2001: Ahmed et al, 2001: Bork et al, 2001: Adato et al, 
2002: Weil et al, 2003: Weston et al, 2004: van Wijk et al, 2006: Ebermann et al, 2007). 
Although Usher’s syndrome genes represent a number of different protein classes, there 
is evidence that many of the proteins interact, forming an Usher protein network 
(Saihan et al, 2009). 
 
1.4.3.1 The Usher protein network 
Mutations of the individual proteins that make up Usher type 1 produce characteristic 
small individual clumps of randomly distributed hair bundles (Lefèvre et al, 2008). As a 
group, the Usher type I proteins consist of myosin VIIa, SANS, harmonin b, CDH23 
and PCDH15 (Chen et al, 1996: Verpy et al, 2000: Udovichenko et al, 2002: Kikkawa 
et al, 2003: Weil et al, 2003: Adato et al, 2005: Pan et al, 2009) (Figure 1.8). During 
hair bundle development, the myosin VIIa tail interacts with the harmonin b PDZ 1 
domain, thereby transporting harmonin b to the top of the stereocilia where its PDZ 2 
domain anchors the CDH23 part of the tip link (Boëda et al, 2002: Lefèvre et al, 2008). 
Although it has been shown that SANS interacts directly with harmonin b via its PDZ 1 
and PDZ 2 domains, and that SANS is critical for the cohesion of the developing hair 
bundle (Weil et al, 2003), its mechanism of function is still unclear.  
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Figure 1.9 illustrates the domains of Usher type I proteins. The complexity of the Usher 
protein interactome continues to increase as shown by the interaction of harmonin b 
with members of the USH 2 family usherin and Vlgr1 via its PDZ 1 domain (Reiners et 
al, 2005) (Figure 1.8). Furthermore, a new USH1 locus (designated USH1H) has 
recently been reported in two large Pakistani consanguineous families (Ahmed et al, 
2009). 
 
Usher Type Usher syndrome locus Gene symbol Protein name and class  
USH1 USH1B MYO7A myosin VIIa - motor protein 
USH1 USH1C USH1C harmonin b – scaffold protein 
USH1 USH1D CDH23 cadherin 23 – cell to cell 
adhesion protein 
USH1 USH1F PCDH15 protocadherin15 - cell to cell 
adhesion protein 
USH1 USH1G USH1G SANS - scaffold protein 
USH2 USH2A USH2A usherin – transmembrane 
protein 
USH2 USH2C VLGR1 Mass1 – transmembrane 
receptor protein 
USH2 USH2D WHRN whirlin - scaffold protein 
USH3 USH3A USH3A clarin1 - transmembrane protein 
 
Table 1.1 Usher’s syndrome type, loci, gene symbol, protein names and class. 
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Figure 1.8 Illustration of the interaction of Usher type 1 and type 2 proteins (adapted from 
Friedman et al, 2007). Non-Usher proteins (myosin XVa and myosin VI) have been included for 
completeness. 
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1.4.4 Non-Usher syndrome related myosins  
In addition to myosin VIIa, which forms a part of the Usher type I network, a number of 
other myosins are now known to play a role in hair bundle development. These include 
myosin XVa, myosin VI and myosin IIIa.  
In the hair bundle, myosin XVa  (Figure 1.10) is concentrated at the tip of the stereocilia 
in a height dependent manner, hence the taller the stereocilia, the larger the amount of 
myosin XVa (Rzadzinska et al, 2004). Indeed, myosin XVa is essential for the creation 
of the hair bundle staircase, as the hair bundles of myosin XVa mutants lack a defined 
staircase, and additionally are much shorter than their wild type counterparts, resulting 
in hearing loss in shaker 2 mice (Anderson et al, 2000: Gong et al, 2006).  
 
 
Figure 1.10 Myosin XVa domains: MyTH4 (myosin tail homology 4), IQ (isoleucine- 
glutamine motifs), FERM (band 4.1, ezrin, radixin, moesin), SH3 (Src homology 3).  
Adapted from Belyantseva et al (2005). 
 
Even though it is not an Usher’s syndrome protein, the shortened hair bundle phenotype 
seen in myosin XVa mutants is similar to that of the deaf mouse strain “whirler”, which 
lacks the USH2D scaffold protein whirlin (Delprat et al, 2005: Mogensen et al, 2007). 
Whirlin exists as two isoforms, short and long: the long isoform consists of three PDZ 
domains and a proline rich region, while the short isoform contains the proline rich 
region and PDZ 3 domain only (Delprat et al, 2005: van Wijk et al, 2006) (Figure 1.11). 
Along with myosin XVa, whirlin is known to have an important role in stereocilia 
elongation and it has been demonstrated that myosin XVa can interact with the short 
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whirlin isoform with its SH3-MyTH4 region, or with the PDZ 1 and PDZ 2 domains of 
the long whirlin isoform with its MyTH4-FERM region (Delprat et al, 2005). Thus 
myosin XVa interacts with and is thought to transport whirlin to the tips of the 
stereocilia (Belyantseva et al, 2005, Kikkawa et al, 2005), although it is possible that 
myosin XVa also interacts with proteins other than whirlin that are important in hair 
bundle development (Mustapha et al, 2007). 
 
 
Figure 1.11Whirlin domains: PDZ (PDZ (postsynaptic density 95, PSD-95; discs large, 
 Dlg; zonula occludens-1, ZO-1). Adapted from Belyantseva et al (2005). 
 
Myosin VI (Figure 1.12) is unusual for being the only myosin to move towards the 
minus end of actin filaments (Wells et al, 1999). In Snell’s waltzer mice, which have a 
null mutation for myosin VI (Friedman et al, 1999), and Tailchaser mice, in which a 
missense mutation disrupts myosin VI function (Hertzano et al, 2008), there is 
membrane fusion at the base of the stereocilia as well as the formation of giant 
stereocilia (Friedman et al, 1999: Self et al, 1999: Hertzano et al, 2008). This has led to 
the proposal that myosin VI acts as an anchor, tethering the hair cell apical membrane to 
the cuticular plate via its head domain. 
 
 
Figure 1.12 Myosin VI domains: CaM (calmodulin binding motif), CC (coiled-coil). Adapted 
from Sweeney and Houdusse (2007). 
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The link between myosin IIIa (Figure 1.13) and hearing loss was first established by 
Walsh et al (2002), and since then, myosin IIIa has demonstrated motor domain 
dependent localisation to the tip of the hair bundle (Schneider et al, 2006). It is possible 
that myosin IIIa has a role in regulating stereocilia height as deletion of the kinase 
domain results in abnormally elongated stereocilia as well as bulging of the stereocilia 
tip (Schneider et al, 2006). In contrast, another study has shown that over-expression of 
myosin IIIa, in conjunction with espin over-expression, also causes stereocilia 
elongation (Salles et al, 2009). 
 
 
Figure 1.13 Myosin IIIa domains: IQ (isoleucine-glutamine motifs), 3THD (class 3 tail 
homology domains). Adapted from Salles et al (2009). 
 
1.5 Regeneration of hair bundles 
Whether, and to what extent, hair cells recover from damage due to noise or drugs (such 
as aminoglycosides) is species dependent. In zebrafish, hair cells and hair bundles 
recover to pre-treatment numbers 14 days after ablation of saccular hair cells by noise 
(Schuck and Smith, 2009), although a hair-cell like phenotype has been documented as 
early as 24-36 hours after copper sulphate or neomycin treatment (Harris et al, 2003: 
Hernández et al, 2007). It appears that zebrafish can generate new hair cells from 
supporting cells that re-enter the cell cycle and create daughter cells, which then 
differentiate into hair cells (proliferative regeneration). Creation of new hair cells in 
zebrafish can also occur by transdifferentiation, where existing supporting cells 
transform into hair cells without mitosis, less severe damage may induce 
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transdifferentiation while more severe damage may need proliferative regeneration for 
complete hair cell recovery (Hernández et al, 2007). Furthermore, by looking at cell 
morphology and by using non-mitotic hair-cell markers as well as markers for mitosis 
such as bromodeoxyuridine (Li and Forge, 1997: Steyger et al, 1997: Zheng and Gao, 
1997: Avallone et al, 2008: Kaiser et al, 2009), it has been shown that both proliferative 
regeneration and transdifferentiation are used to regenerate hair cells in amphibians 
(Jones and Corwin, 1996: Balak et al, 1990: Baird et al, 2000: Taylor and Forge, 2005), 
birds (Duncan et al, 2006: Cafaro et al, 2007) and the mammalian vestibular organs 
(Warchol et al, 1993: Forge et al, 1993: Li and Forge, 1997: Kawamoto et al, 2009).  
Behavioural studies using birds have shown that these new hair cells are functional, the 
quality of birdsong was found to degenerate with ototoxic treatment, but recovers 
commensurately with hair cell recovery, although hair cell recovery can lag behind 
birdsong recovery (Dooling et al, 1997: Marean et al, 1998: Woolley and Rubel, 2002). 
However, function does not always appear to fully recover to pre-hair cell damage 
levels, with electrophysiological testing showing a residue of ~ 15-20 dB hearing loss at 
all frequencies in aminoglycoside treated birds (Müller and Smolders, 1998), while 
another study shows a residual loss in the high frequencies only (Irvine et al, 2009). In 
mammals, transducer currents from vestibular hair cells are abolished by gentamicin 
treatment, but return with hair bundle recovery over the following 13-17 days (Taura et 
al, 2006), indicating that damaged vestibular hair cells show functional, as well as 
morphological, recovery. 
 
The regulatory mechanisms of proliferative regeneration and transdifferentiation have 
yet to be elucidated. However, there is evidence to show that in zebrafish, the Notch 
signalling pathway, which plays a role in embryonic hair cell differentiation, may have 
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a role in regulating the number of hair cells regenerated after neomycin exposure 
(Haddon et al, 1998: Ma et al, 2008). In addition, over-expression of the basic helix-
loop-helix (bHLH) transcription factor Hath1 (also known as Atoh1 or Math1) in the 
gentamicin treated rat utricle results in the generation of new hair cells via 
transdifferentiation (Shou et al, 2003).  
The presence of growth factors is essential for normal inner ear development (Represa 
et al, 1988: Després et al, 1991). This observation has led to suggestions that growth 
factors may also promote hair cell regeneration (Zheng et al, 1997: Doetzlhofer et al, 
2004), and heregulin, a member of the epidermal growth factor family, has been shown 
to promote proliferative regeneration in gentamicin treated rat utricles (Zheng et al, 
1999). In the chick, both basic fibroblast growth factor (bFGF) and nerve growth factor 
(NGF) show up-regulation in response to noise-induced hair cell loss. However, the 
relationship between growth factor up-regulation and hair cell loss may not be straight 
forward, with 8 hours daily exposure to 120 dB SPL for 5 days (total of 40 hours noise 
exposure) causing greater bFGF and NGF up-regulation than continuous exposure to 
120 dB SPL for 72 hours (Sliwinska-Kowalska et al, 2005). 
 
1.5.1 Regeneration of mammalian auditory hair cells 
The ability of hair cells to repair and regenerate, especially in the avian auditory and 
mammalian vestibular systems, has led to hopes that this could be repeated in 
mammalian auditory hair and supporting cells. It has been shown that hair cells, which 
survive even severe mechanical trauma, can self-repair to a certain extent (Sobkowicz et 
al, 1992), although where hair cells are entirely missing, no regeneration occurs (Quint 
et al, 1998: Lenoir et al, 1999: Yamasoba and Kondo, 2006).  
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Nevertheless, growth factors may well support the survival of any remaining cells in an 
aminoglycoside-damaged organ of Corti (Romand and Chardin, 1999: Daudet et al, 
2002). 
The transcription factor Atoh1 is crucial for normal mammalian hair cell development 
(Gubbels et al, 2008), and has been reported to induce the transdifferentiation of 
supporting cells into hair cells (Kawamoto et al, 2003). Where cochlear hair cells were 
removed by a combination of aminoglycoside and diuretic drugs, both inner and outer 
hair cells were apparently regenerated by supporting cells over-expressing Atoh1, 
although OHCs were often mis-orientated and incompletely differentiated (Izumikawa 
et al, 2005). Moreover, these new hair cells were found to be functional on 
electrophysiological testing, although as the authors of the study point out, the condition 
of the OHCs may not fully restore their function as the active cochlea amplifier 
(Izumikawa et al, 2005).  
 
The Notch pathway is one of the major signalling pathways involved in almost all 
developmental decisions in multi-cellular organisms (Abelló and Alsina, 2007) and in 
the developing inner ear, Notch suppresses Atoh1 expression by regulation of Hes1 and 
Hes5, bHLH transcription regulators which antagonize Atoh1 expression (Zheng et al, 
2000). Due to the potential of Atoh1/Math1/Hath1 to induce cochlear hair cell 
regeneration, the Notch pathway is being investigated for a possible role in this process. 
The results have been paradoxical so far. Some workers have found increased Hes1 and 
Hes5 labelling in the cochlea of adult guinea pigs in response to aminoglycoside 
damage (Batts et al, 2009), suggesting the suppression of potential Atoh1 expression. In 
contrast, another study found no such increase in adult Hes5-GTP transgenic mice in 
response to aminoglycoside and diuretic damage (Hartman et al, 2009). 
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The cyclin-dependent kinase inhibitor p27Kip1 (Cdkn1B) is also being investigated as a 
potential target for modulating hair cell regeneration. In the normal cochlea, p27Kip1 is 
expressed in post-mitotic supporting cells to prevent them from re-entering the cell 
cycle, hence in p27Kip1 deficient mice there is overproduction of inner and outer hair 
cells as well as supporting cells (Löwenheim et al, 1999a: Kanzaki et al, 2006). Ex vivo 
post mitotic supporting cells have been shown to down regulate p27Kip1 and proliferate 
in the presence of periotic mesenchymal cells, which normally support embryonic 
cochlea development, with a resulting portion of the new cells differentiating into hair 
cells, although transdifferentiation was also observed (White et al, 2006: Ono et al, 
2009). 
 
1.5.2 Recovery of mammalian auditory hair cells and hair bundles  
Where there is non-fatal injury to the hair cell, but there is enough damage to cause the 
loss of the hair bundle, hair cell survival is possible. Hair cells from the bullfrog saccule 
which survive aminoglycoside damage have been shown to exist in a bundle-free state 
for at least a week (Gale et al, 2002), while bundle-free hair cells from aminoglycoside 
treated P3 rat utricles can survive for at least 11 days (Zheng et al, 1999).  
In the mammalian organ of Corti, mechanically damaged, bundle-free neonatal hair 
cells can also survive (Sobkowicz et al, 1992: Sobkowicz et al, 1997), and even show 
signs of hair bundle repair by reforming the kinocilium (Sobkowicz et al, 1995). The 
ability of the mammalian auditory hair cell to repair itself is further demonstrated by the 
decrease in cell surface blebs found on cochlear cultures of P1-3 mice after 2 hours of 
recovery following a short (30 minutes) treatment with neomycin (Goodyear et al, 
2008). In the mature mammalian cochlea, studies have shown that both hair bundle tip 
links and side connectors can be damaged by noise exposure with concomitant hair 
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bundle disarray, fusion of stereocilia and hearing loss (Pickles et al, 1987: Clark and 
Pickles, 1996). However, side connectors damaged by noise exposure have been shown 
to undergo repair, returning the hair bundle to its intact state in 14-28 days, although 
other ultra-structural damage such as blebs remained (Tsuprun et al, 2003).  
The mechanism of this hair bundle recovery has yet to be fully elucidated, but it has 
been suggested that the continuous turnover of actin filaments may play a part by 
transporting the required proteins for repair to the necessary location along the 
stereocilia (Schneider et al, 2002: Rzadzinska et al, 2004).  
 
1.6 The role of phosphorylation in actin cytoskeleton regulation 
Hair bundle development, maintenance and regeneration necessarily involve the 
regulation of actin polymerisation and depolymerisation. However, aside from the 
possible transportation of proteins within the stereocilium by treadmilling (Naoz et al, 
2008), very little else is known about stereocilia actin regulation.  
In non-hair cells, actin is known to be closely regulated as it is involved in a myriad of 
dynamic cellular processes such as cell migration, mitosis, gene expression or the 
trafficking of intracellular proteins and organelles (Gieni and Hendzel, 2009: Hall, 
2009: Kunda and Baum, 2009) The utilization of protein kinases for phosphorylation 
plays an important role in actin regulation. Currently, there appear to be three major 
processes that regulate actin within cells, which are nominally independent, but are 
highly interconnected: the capping and uncapping of actin filaments, actin filament 
depolymerisation and de novo actin nucleation. Each of these three processes are 
regulated by different proteins such as the family of small GTPases, Rho, Rac and 
Cdc42, and by phospholipids such as phosphatidylinositol 4,5-bisphosphate (PIP2), both 
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of which depend on both upstream and downstream phosphorylation to exert their 
effects on the actin cytoskeleton. 
 
1.6.1 Protein kinases and regulation of actin filament un/capping  
Two important proteins involved in the capping of existing filaments to prevent 
spontaneous actin polymerisation are gelsolin (Harris and Weeds, 1984) and capping 
protein (also known as CapZ or β-actinin) (Casella et al, 1986: Caldwell et al, 1989) 
(Figure 1.14). Gelsolin is a ~ 90 kDa member of the gelsolin superfamily, and contains 
six homologous repeats of a domain named gelsolin-like (G) domain, with two actin 
binding domains situated at the N-terminus and C-terminus respectively (Chaponnier et 
al, 1986: Silacci et al, 2004). In order to cap an actin filament, gelsolin binds two 
opposing actin strands with its actin binding domains, and in response to an increase in 
intracellular Ca2+ concentration, undergoes a conformational change which severs the 
filament, leaving gelsolin attached to the barbed end as a cap (McLaughlin et al, 1993: 
Silacci et al, 2004). Protein kinase C (PKC) signalling has been shown to be involved in 
gelsolin expression. As part of its anti-tumour effects, the histone deacetylase inhibitor 
apicidin induces the production of gelsolin (Han et al, 2000), but when PKCε is 
inhibited in human cervix cancer cells, apicidin-induced gelsolin expression is 
completely abrogated (Eun et al, 2007). On the other hand, gelsolin severing of actin 
filaments and their subsequent capping can be prevented by the action of the 
phosphoinositides phosphatidylinositol 4-phosphate (PI4P) and PIP2 (Janmey and 
Stossel, 1989), with PIP2 binding to a sequence in the N-terminus that prevents gelsolin 
binding to an actin filament (Yin et al, 1988: Lin et al, 1997). The protein kinase 
phosphatidylinositol 4-phosphate 5 kinase (PI5K), which phosphorylates PI4P to 
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produce PIP2, is important in this process as PI5K ensures the correct localisation of 
PIP2 (El Sayegh et al, 2007).  
CapZ is an αβ heterodimer with an α subunit of 32–36 kDa and a β subunit of 28–32 
kDa (Wear and Cooper, 2004) which form an unusual tertiary structure consisting of 
two C-terminal extensions which bind actin and subsequently causes filament capping 
(Yamashita et al, 2003). 
 
 
Figure 1.14 Actin filament regulation routes and their major regulatory processes. 
 
Previous studies showed that PIP2 inhibits the action of CapZ in a concentration 
dependent manner (Schafer et al, 1996: DiNubile and Huang, 1997), possibly by 
binding to the C-terminal extension of the α subunit, therefore preventing filament 
capping (Kim et al, 2007). The level of available PIP2 is therefore an important factor in 
actin regulation. Among the many ways in which PKC influences the actin 
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cytoskeleton, PKC can phosphorylate PIP2-sequestering proteins such as the 
myristoylated alanine-rich C-kinase substrate (MARCKS), resulting in an increase of 
PIP2, and thereby encouraging actin filament assembly (Glaser et al, 1996). 
Actin filament capping can also be prevented by the Ena/VASP family (Figure 1.14), a 
family of proteins that have an N-terminal Ena/VASP homology 1 (EVH1) domain, a 
proline-rich domain and a C-terminal EVH2 domain (Bear and Gertler, 2009). One 
method by which Ena/VASP prevents capping is by increasing the rate of filament 
elongation, which it accomplishes even in the presence of capping proteins (Barzik et al, 
2005), possibly via the recruitment of profilin, a protein which promotes the presence of 
ATP-actin monomers (Pasic et al, 2008). Activation of the Ena/VASP proteins is 
dependent on multiple phosphorylation sites that are targets for either cAMP-dependent 
protein kinase (PKA) or cGMP-dependent protein kinase (PKG) (Lebrand et al, 2004). 
How the phosphorylation of specific sites affects Ena/VASP function has not been fully 
elucidated, but it is known that phosphorylation of Ena/VASP by PKA is essential for 
its correct localisation (Benz et al, 2009). 
 
1.6.2 Protein kinases in actin depolymerisation and de novo actin nucleation 
ADF/cofilin is one of a family of important F-actin regulatory proteins. These proteins 
have highly conserved G-actin and F-actin binding domains, as well as a PIP2 binding 
domain (Bamburg, 1999). ADF/cofilin increases actin filament depolymerisation by 
increasing the rate of disassociation of ADP-actin at the minus end of the actin filament, 
and once bound to an ADP-actin monomer, ADF/cofilin inhibits nucleotide exchange, 
thus decreasing the level of ATP-actin monomers ready for incorporation at the plus end 
of the filament (Chen et al, 2000: Paavilainen et al, 2008). To aid in actin filament 
depolymerisation, ADF/cofilin can also sever actin filaments by using an unusual 
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mechanism: ADF/cofilin binding to an actin filament causes the filament to twist, thus 
weakening the lateral links between actin monomers in the filament, leading to filament 
fragmentation (McGough and Chiu, 1999: Bobkov et al, 2006). The ultimate 
polymerisation or depolymerisation action of ADF/cofilin on actin filaments however, 
may depend on the local concentration within the cell, as high concentrations of 
ADF/cofilin have been shown to favour creation of new actin filaments 
(Andrianantoandro and Pollard, 2006). Regulation of ADF/cofilin activity is effected by 
the serine protein kinases Lim kinase 1 (LIMK1) and Lim kinase 2 (LIMK2) (Figure 
1.14), which inactivate ADF/cofilin by phosphorylation of the ADF/cofilin N-terminal 
serine residue (Maciver and Hussey, 2002). The LIM kinases are themselves 
downstream effectors of the Rho, Rac and Cdc42 family, with Rac and Cdc42 
mediating the phosphorylation of LIMK1 by p21-activated kinase (Pak1) at threonine 
508 (Edwards et al, 1999). The threonine 508 residue of LIMK1 is also the target for 
phosphorylation by Rho-associated kinase (ROCK) (Ohashi et al, 2000), and in 
addition, ROCK is thought to phosphorylate LIMK2 (Vardouli et al, 2005). 
 
Actin nucleation is the first step in the formation of new actin filaments, and the role of 
the actin nucleation core is provided by the Arp2/3 complex, which consist of actin 
related proteins 2 and 3 (Arp2/3) as well as 5 other subunits (Welch et al, 1997). Arp2/3 
is activated by the Wiskott-Aldrich syndrome family proteins (WASP), including 
WASP, N-WASP and WAVE 1-3 (Machesky and Insall, 1998: Yarar et al, 1999). 
Although WASP and WAVE differ in their N-termini, with WASP containing a WH1 
domain and WAVE a novel SHD/WHD domain, both WASP and WAVE contain a 
highly basic region, a GBD/CRIB motif, a proline-rich region, and the Arp2/3 activating 
VCA region in the C-terminal (Miki and Takenawa, 2003).  
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While the VCA region can be masked by WASP auto-inhibition, binding of Cdc42 to 
the GBD/CRIB motif and PIP2 to the basic region releases this inhibition, resulting in 
actin nucleation by Arp2/3 (Kim et al, 2000: Papayannopoulos et al, 2005). 
Furthermore, profilin has been shown to cause partial/full release of WASP auto-
inhibition by binding to the proline-rich domain of WASP by its SH3 domain (Suetsugu 
et al, 1998). It has recently been suggested that in addition to WASP activation, 
phosphorylation of the threonine 237 and 238 residues in the Arp2 protein is also 
necessary for Arp 2/3-induced actin nucleation (LeClaire III et al, 2008).  
Different members of the Rho, Rac and CDC42 family are thought to show a degree of 
selectivity in WASP activation, with Cdc42 more efficient at WASP activation, while 
Rac shows greater potency for N-WASP activation as well as being the activator for the 
WAVE proteins (Yamazaki et al, 2007: Tomasevic et al, 2007: Abou-Kheir et al, 2008). 
As well as regulation by the Rho family, both WASP and WAVE proteins have multiple 
phosphorylation sites that are important for localisation or for actin binding affinity via 
their VCA regions (Blundell et al, 2009: Pocha and Cory, 2009). 
Rho also has a role in the activation of the Diaphanous-related formins, another group 
of actin nucleation proteins, which contain a C-terminal formin homology 2 (FH2) 
domain that mediates their effects on actin, with the N-terminus providing the site for 
auto-inhibition (Seth et al, 2006). The N-terminus of the Diaphanous-related formins 
contains the GTPase-binding domain, which on Rho binding releases the auto-
inhibition, thereby recruiting the diaphanous-related formins to the plasma membrane 
(Rose et al, 2005), with further interaction with ROCK initiating nucleation of new actin 
filaments (Hannemann et al, 2008). 
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1.6.3 c-Jun NH2-terminal kinase: a downstream effector of Rho, Rac and Cdc42 
As the section above illustrates, there are many effector proteins downstream of Rho, 
Rac and Cdc42 that have roles in regulating the cytoskeleton. These effector proteins 
can act by either initiating further downstream phosphorylation, like that carried out by 
the Pak family of protein kinases (Sells et al, 1997: Parrini et al, 2009), or by direct 
actin binding, such as for Filamin A (Nunnally et al, 1981: Bustelo et al, 2007). The c-
Jun N-terminal kinase (JNK) is a member of the mitogen-activated protein kinase 
(MAPK) family and among the protein kinases potentially activated downstream of 
Rho, Rac and Cdc42 signalling, JNK has emerged as an important regulator of actin. 
Thus in morphogenesis, mouse double mutants for Jnk1-/- and Jnk2-/- do not survive 
embryogenesis due to failure of neural tube closure (Kuan et al, 1999), a complex 
process dependent, among other factors, on the precise actin-generated movements of 
epithelial cell sheets (Morriss-Kay and Tuckett, 1985: Moephuli et al, 1997: Hildebrand 
and Soriano, 1999: Xia and Karin, 2004). In inflammation, wound closure is prevented 
in the presence of JNK inhibitors due to inhibition of lamellipodia formation (Altan and 
Fenteany, 2008: Nomachi et al, 2008) and in bacterial infection, the mobility and 
migration of neutrophils enabled by the actin cytoskeleton involves the activation of the 
JNK pathway (Arndt et al, 2005: Zemans and Arndt, 2009). Three mammalian JNK 
genes encode for JNK proteins I, II and III, which may vary in their distribution in 
different tissue types (Yang et al, 1997). As a consequence of splicing, there are at least 
10 known JNK isoforms (Gupta et al, 1996), which are activated by phosphorylation of 
specific threonine and tyrosine residues (Dérijard et al, 1994). Upon activation, JNK 
phosphorylates the transcription factor c-Jun at Ser-63 and Ser-73 (Dérijard et al, 1994), 
leading to apoptosis in a wide range of cell types such as neurons (Liu et al, 2009), 
retinal cells (Guma et al, 2009) and cardiac cells (Izumi et al, 2000).  
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1.6.3.1 c-Jun NH2-terminal kinase inhibition and auditory hair cells  
In the organ of Corti, activation of the JNK pathway leading to apoptosis has been 
demonstrated in hair cells subjected to aminoglycoside or noise damage (Pirvola et al, 
2000: Ylikoski et al, 2002). In common with JNK-induced apoptosis in other cell types, 
apoptosis in hair cells is due to JNK-induced mitochondrial release of cytochrome c 
leading to apoptosis without further gene expression (Tournier et al, 2000: Aoki et al, 
2002), although other receptor mediated pathways involving JNK and requiring further 
gene expression are likely (Yang et al, 1997: Dickens et al, 1997). However, where the 
hair cells have been treated with JNK inhibitor during or after trauma, studies have 
shown that there is reduced hair cell loss as well as a reduction in hearing loss (Coleman 
et al, 2007: Eshraghi et al, 2007: Wang et al, 2007). Nevertheless, JNK inhibition is not 
always protective, even though the JNK-induced apoptosis pathway is activated in hair 
cells treated with the chemotherapeutic agent cisplatin, JNK inhibitors were shown to 
actually potentiate cisplatin oto-toxicity (Wang et al, 2004). 
 
1.7 Aims 
To assess the impact of protein kinase inhibitors on the morphology of immature mouse 
hair bundles by a variety of biochemical and microscopic techniques. All of the protein 
kinases screened are known to influence actin regulation in vivo, in a variety of cell 
types. Furthermore, as auditory hair cells have been shown to recover from limited 
mechanical or drug induced trauma, a second aim of this project is to look for any signs 
of hair bundle recovery in response to either protein kinase inhibitors or neomycin 
treatment. 
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2.1 Dissection and preparation of mouse cochlear cultures 
Cochlear cultures were prepared using methods described previously (Russell and 
Richardson 1987): CD1 (HaM/ICR) mice aged P1 to P2 were killed by cervical 
dislocation, and sterilised by immersion in 80% ethanol. After being separated from the 
body, the head was dissected mid-sagitally in Hepes-buffered (10 mM, pH 7.2) Hank’s 
balanced salt solution (HBHBSS) (Invitrogen, Paisley, UK), and the brain removed. The 
cochlea was pinched off from the vestibular apparatus and placed in fresh HBHBSS, 
where the cochlear capsule was then removed to reveal the stria vascularis surrounding 
the cochlear duct. After removal of the stria vascularis, the sensory epithelium was 
divided into apical and basal coils by cutting at approximately 360° from the apex.  
Collagen coated coverslips were prepared by pipetting a drop of rat tail collagen Type 1 
(BD Biosciences, Oxford, UK) onto 22 mm round coverslips, these were then exposed 
to ammonia vapour for 10 minutes in a fume cupboard. After 3 washes in autoclaved 
water, the coverslips were transferred to a Columbia staining jar containing 8 ml 
HBHBSS and 4 drops of foetal bovine serum (Biosera, Ringmer, UK). 
Apical and basal coils were plated onto the coverslips and fed with three drops of 
medium (93% DMEM/F12 HAM [Sigma-Aldrich, Dorset, UK], 7% foetal bovine 
serum [Biosera, Ringmer, UK], 10 µg/ml ampicillin). After being sealed into Maximow 
slide assemblies with wax, coils were grown for 24 hours at 37°C.  
 
2.2 Treating cochlear cultures with protein kinase inhibitors  
Coverslips were removed from the Maximow slide assemblies, placed in 35 mm 
diameter plastic Petri dishes, washed once with HBHBSS and incubated with medium 
containing the appropriate protein kinase inhibitor at 37°C in a 5% CO2, 95% air 
incubator. A list of the protein kinase inhibitors and the concentrations used are 
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provided in Table 2.1. Compounds were dissolved in dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich, Dorset, UK) or water as stock concentrations. Equivalent volumes of 
DMSO or water were added to control culture medium. 
 
Protein kinase 
inhibitors 
 
Target Concentrations used Time 
(hours) 
Akt Inhibitor IV PKB (IC50 625 nM) 1 µM 24 
C3 transferase Rho A, B, C  2 µg/ml, 4 µg/ml 6, 14 
GSK-3 Inhibitor IX GSK-3α/β (IC50 5 nM) 50 nM, 100 nM 24 
JNK Inhibitor I  c-Jun NH2- terminal kinase 
(IC50 1 µM) 
5 µM 5, 14, 
24, 48 
JNK Inhibitor I 
negative control 
-- 5 µM 14, 24, 
48 
JNK Inhibitor II c-Jun NH2- terminal kinase 
(IC50 40 nM) 
50 µM 10, 24 
JNK Inhibitor V c-Jun NH2- terminal kinase 
(IC50 220 nM) 
0.2 µM, 1 µM, 2 µM 24, 48 
Staurosporine PKC (IC50 0.7 nM),  
MLCK (IC50 1.3 nM), 
PKA (IC50 7 nM),  
PKG (IC50 8.5 nM).  
CaM kinase II (IC50 20 nM). 
1 nM, 2 nM, 5 nM, 10 
nM 
2, 2.5, 
4, 5, 
10, 14, 
16, 22, 
24, 48 
Specific inhibitors 
of potential 
staurosporine 
targets 
Target Concentrations used Time 
(hours) 
Bisindolylmaleimide 
I (BIM I) 
PKCα (IC50 0.008 µM), 
PKCβI (IC50 0.018 µM), 
PKCδ (IC50 0.21 µM),    
PKCε (IC50 0.132 µM),    
PKC ξ (IC50 5.8 µM). 
10 nM, 1 µM 24 
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Protein Kinase Cθ 
pseudosubstrate 
inhibitor, 
myristoylated: 
Myr-HQRRGAIKQ 
AKV HHVKC-NH2 
PKCθ  1 µM, 10 µM, 40 µM 24 
Rottlerin PKCδ (IC50 3-6 µM), PKCθ  1 µM, 2 µM, 5 µM 16, 24 
ML-7 MLCK (Ki 300 nM) 1 µM, 10 µM, 50 µM 24, 48 
H-89 PKA (Ki 48 nM) 10 µM, 100 µM 24 
KT5823 PKG (Ki 234 nM) 1 µM, 5 µM, 10 µM 24 
KN-93 CaM kinase II (Ki 370 nM) 5 µM, 50 µM 24 
 
Table 2.1 Protein kinase inhibitors: cellular targets, IC50, concentrations used and time points. 
IC50 = concentration required to produce 50% inhibition, Ki = inhibitor concentration at which 
50% inhibition is observed. 
 
2.3 Treating cochlear cultures with neomycin  
Coverslips were removed from the Maximow slide assemblies, placed in 35 mm 
diameter plastic Petri dishes, washed once with HBHBSS and incubated with medium 
containing the desired concentration of neomycin at 37°C in a 5% CO2, 95% air 
incubator or at room temperature (~ 23°C). For experiments performed at room 
temperature, Leibovitz's L-15 (Invitrogen, Paisley, UK) medium was used. 
 
2.4 Transfection of cochlear cultures by gene gun  
2.4.1 Preparation of plasmid DNA-coated gold particle “bullets” 
In order to adhere plasmid DNA to gold particles, spermidine solution was made as 
follows: fresh spermidine hydrochloride stock was made up with 31.75 mg spermidine 
hydrochloride (Sigma-Aldrich, Dorset, UK) in 250 µl of sterile water, and 5 µl of this 
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0.5 M spermidine hydrochloride solution was then added to 45 µl of sterile water to 
give a final concentration of 0.05 M spermidine hydrochloride. Gold particles (25 mg of 
1 µm particles) (Biorad, Hemel Hempstead, UK) were added to 50 µl of the 0.05 M 
spermidine hydrochloride solution and vortexed, followed by brief sonication. EGFP-
PLCδ1PH plasmid DNA (100 µg) was then added to the spermidine hydrochloride 
solution, which was subsequently vortexed for 5 seconds, immediately after which 50 µl 
of autoclaved 1 M CaCl2 was added, the solution vortexed, and then left to stand for 10 
minutes at room temperature. This solution was spun for 15 seconds, the supernatant 
discarded and the remaining pellet vortexed briefly. 1 ml of 100% ethanol was added to 
the vortexed pellet and spun for 15 seconds, after which the supernatant was discarded 
and the remaining suspension gently pipetted. This was repeated three times in total. 
The pellet was finally re-suspended in 200 µl of polyvinylpyrrolidone (PVP) solution. 
The PVP solution consisted of 10 mg of PVP (Biorad, Hemel Hempstead, UK) in 500 
µl of 100% ethanol, with 35 µl of this solution added to 7 ml of 100% ethanol, giving a 
final PVP concentration of 0.02 mg/ml. 
To create the gene gun bullets, Tefzel tubing (Biorad, Hemel Hempstead, UK) in the 
tubing preparation station Biolistic PDS-100/HE (Biorad, Hemel Hempstead, UK) was 
filled with the plasma DNA-coated gold particle solution via a syringe. After rotation of 
the tubing for 30 seconds, the interior of the tube was dried by N2 flow for 5 minutes. 
The tubing was removed from the preparation station, cut into 13 mm lengths and stored 
at 4°C with silica crystals.  
 
2.4.2 Gene gun transfection 
Plasmid DNA bullets were loaded into the cartridge of the Helios gene gun system 
(Biorad, Hemel Hempstead, UK). Cochlear cultures were removed from Maximow slide 
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assemblies, placed on the gene gun stand and covered by a high pore-density cell 
culture insert (BD Biosciences, Oxford, UK). After positioning the cochlear culture 
beneath the gene gun muzzle, plasmid DNA was fired at the culture at 120 psi, 
following which the culture was removed to a 35 mm diameter plastic Petri dish with 
fresh media, examined under light microscopy for distribution of gold particles and then 
incubated at 37°C. 
 
2.5 Annexin V detection of phosphatidylserine externalization 
Coverslips with adherent cultures were transferred from the petri dish to a glass 
bottomed Perspex viewing chamber containing 0.5 ml HBHBSS. Alexa Fluor 488 
annexin V (Invitrogen, Paisley, UK) was added to a dilution of 1:50. Cultures were 
viewed using a x63 water immersion lens and images were captured 5 minutes after the 
onset of annexin V labelling. 
 
2.6 FM1-43 dye loading 
Coverslips were removed from the petri dish and washed in a Columbia staining jar 
containing HBHBSS. After dipping in 3 µM FM1-43 (Molecular Probes, Paisley, UK) 
for 10 seconds, the coverslips were washed 3 times with fresh HBHBSS, placed in a 
glass bottomed Perspex viewing chamber containing 0.5 ml HBHBSS and examined 
under a x63 water immersion lens. 
 
2.7 Fixing of cochlear cultures for fluorescent and confocal imaging 
Cultures were washed with HBHBSS and fixed in 4% paraformaldehyde (Agar 
Scientific, Essex, UK) in 0.1 M sodium phosphate buffer (pH 7.3) for 30 minutes, then 
washed three times in phosphate buffered saline (PBS). Cultures were stained with a 
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1:1000 dilution of rhodamine conjugated phalloidin (Sigma-Aldrich, Dorset, UK) or a 
1:300 dilution of Texas Red phalloidin (Invitrogen, Paisley, UK) in PBS with 10% 
inactivated horse serum and 0.1% Triton X-100 for 1.5 hours at room temperature. 
After staining, cultures were rinsed three times in PBS and mounted onto glass slides 
with Vectashield mounting medium (Vector Laboratories, Peterborough, UK).  
 
2.8 Propidium iodide loading 
Cochlear cultures were fixed as above, then incubated in 500 nM propidium iodide for 5 
minutes before being mounted and examined under fluorescence microscopy. 
 
2.9 Antibody staining of cochlear cultures 
After fixation, the cultures were placed in PBS with 10% heat-inactivated horse serum 
and 0.1% Triton X-100. Antibody (see below) was added to the required concentration 
and cultures were incubated overnight at 4 °C with constant rotation. Following 3 
washes with PBS, the cultures were then incubated with the secondary antibody (see 
below) diluted in PBS with 10% heat-inactivated horse serum and 0.1% Triton X-100 
containing 1:1000 dilution of rhodamine conjugated phalloidin (Sigma-Aldrich, Dorset, 
UK) or 1:300 dilution Texas Red phalloidin (Invitrogen, Paisley, UK) for 2 hours at 
room temperature with rotation. Cultures were mounted as described above. 
Primary antibodies were used as follows: rabbit anti-phospho-ezrin (Thr567)/radixin 
(Thr564)/moesin (Thr 558) (phos-ERM) (Cell Signalling Technologies, Massachusetts, 
US) at a 1:50 dilution, rabbit anti-radixin (Sigma-Aldrich, Dorset, UK) at a 1:100 
dilution. Secondary antibodies were used as follows: Alexa Fluor® 488 F(ab')2 
fragment of goat anti-rabbit IgG (H+L) (Invitrogen, Paisley, UK) at a 1:500 dilution, 
and polyclonal swine anti-rabbit immunoglobulins/FITC (DakoCytomation, Ely, UK) at 
a 1:100 dilution. 
 58 
2.10 Scanning electron microscopy 
Cultures were washed with HBHBSS and fixed in 2.5% glutaraldehyde (TAAB, 
Berkshire, UK) in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 hours at room 
temperature, rinsed three times in 0.1 M sodium cacodylate buffer, and post-fixed with 
0.1 M sodium cacodylate-buffered 1% osmium tetroxide (TAAB, Berkshire, UK) for 1 
hour. Tissue pieces were finally washed twice in 0.1 M cacodylate buffer, once with 
water and then dehydrated through a series of ascending concentrations of ethanol 
(50%, 70%, 80 %, 90%) for a minimum of 10 minutes in each ethanol concentration. 
Tissue pieces were further dehydrated with three 100% ethanol washes of 20 minutes 
per wash, and one final 100% dehydration step was carried out overnight at 4 ºC. 
Samples were critical point dried, mounted on aluminium specimen stubs (TAAB, 
Berkshire, UK) and sputter coated with gold particles. 
 
2.11 Transmission electron microscopy 
Cultures were washed with HBHBSS and fixed with 2.5% glutaraldehyde (TAAB, 
Berkshire, UK) in 0.1 M sodium cacodylate buffer (pH 7.2) containing 1% tannic acid 
(TAAB, Berkshire, UK) for 2 hours at room temperature. After washing three times 
with 0.1 M sodium cacodylate buffer, the cultures were post-fixed with 0.1 M sodium 
cacodylate-buffered 1% osmium tetroxide (TAAB, Berkshire, UK) for 1 hour. Tissue 
pieces were finally washed twice in 0.1 M sodium cacodylate buffer and once with 
water. Dehydration of the tissue was carried out through a series of ascending 
concentrations of ethanol (50%, 70%, 80 %, 90% 100%), for a minimum of 5 minutes 
in each ethanol concentration. The tissue was further dehydrated twice in propylene 
oxide for a minimum of 10 minutes per wash, then transferred to a 1:1 propylene oxide: 
epoxy resin (TAAB 812 resin, dodecenyl succinic anhydride [DDSA], methyl nadic 
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anhydride [MNA], [2,4,6- Tri [Dimethylaminomethyl] phenol] [DMP-30]) (TAAB, 
Berkshire, UK) solution for one hour, before being transferred to a 1:3 propylene oxide: 
epoxy resin solution overnight. The tissues were then placed in 100% epoxy resin for a 
further 8 hours, and finally embedded in fresh pure resin in BEEM capsules (TAAB, 
Berkshire, UK). These resin-embedded samples were cured at 60°C for 24 hours. 
Ultrathin sections (100 and 150 nm thick) were cut using a Diatome diamond knife 
(TAAB, Berkshire, UK) on a Reichert Ultracut E microtome (Leica, Milton Keynes, 
UK) before being mounted on copper grids. Sections were stained with 1% aqueous 
uranyl acetate for 30 minutes, and then washed 3 times with water. Further staining was 
carried out according to Reynolds (1963). In brief, lead citrate solution was prepared 
with 45 µg/ml lead nitrate, 25 µg/ml trisodium citrate and 6 µg/ml sodium hydroxide, 
and used to stain grids for 8 minutes, after which the grids were washed 4 times with 
water and allowed to dry. 
 
2.12 Labelling cochlear cultures with cationic ferritin 
Coverslips with adherent cultures were removed from Maximow slide assemblies, 
placed in 35-mm diameter plastic Petri dishes, washed once with HBHBSS, and 
incubated with 10 nM staurosporine (InSolution™ Staurosporine, Calbiochem) for 4 
hours at 37 ºC. The cultures were then chilled on ice before being washed 3 times with 2 
ml of cold HEPES (10 mM, pH 7.0) buffered DMEM/F12 (serum free) (Sigma-Aldrich, 
Dorset, UK). Medium containing 1 mg/ml ferritin (Sigma-Aldrich, Dorset, UK) was 
then added and cultures were incubated on ice for 1 hour. After 3 further washes with 2 
ml HEPES buffered serum-free DMEM/F12, the cultures were further incubated in 10 
nM staurosporine for 4 hours, before being prepared for transmission electron 
microscopy as described above. 
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2.13 Toluidine blue dye staining 
Cochlear cultures embedded in TAAB 812 resin (please see section 2.11 above) were 
cut at a thickness of 1 µm thin using glass knives on a Reichert Ultracut E microtome 
(Leica, Milton Keynes, UK). After being transferred to a glass slide, the sections were 
dried on a hotplate at 80˚C and then stained with Toluidine blue dye for approximately 
30 seconds before the glass slide was removed from the hotplate and the sections 
washed with distilled water. Following further drying, the sections were mounted with 
Histomount (TAAB, Berkshire, UK).  
 
2.14 Microscopy 
A Zeiss Axioplan II microscope with AttoArc HBO 100W (Zeiss, Hertfordshire, UK) 
was used for light and fluorescence microscopy. Confocal images were obtained with a 
Zeiss LSM 510 confocal microscope (Zeiss, Hertfordshire, UK). Scanning electron 
microscopy was carried out with a Leica Leo S240 scanning electron microscope 
(Leica, Nussloch, Germany), and tissue prepared for transmission electron microscopy 
was viewed with a Hitachi 7100 transmission electron microscope (Hitachi, Tokyo, 
Japan). Images were routinely taken from the mid-point of the apical and basal coils. 
 
2.15 Westerns blotting 
2.15.1 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS PAGE) 
The resolving and stacking gels (Table 2.2 and Table 2.3) were prepared using the 
BioRad mini gel system (BioRad, Hertfordshire, UK). Protein samples were then mixed 
with an equal volume of 2x reducing sample buffer (10% glycerol, 3% SDS, 12.5% 4x 
stacking Tris buffer, 0.1 M DTT), boiled at 100°C for 5 minutes, spun to pellet any 
insoluble protein and loaded into the wells. Electrophoreses was carried out at 40 mA 
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(for two gels) for approximately 40 minutes and coloured markers were run alongside 
the samples in at least one lane in each gel. 
 
2.15.2 Semi-dry Western Blotting and detection of proteins 
The proteins separated by SDS-PAGE were subsequently transferred onto Amersham 
Hybond-P polyvinylidene difluoride (PVDF) protein transfer membranes (GE 
Healthcare, Bucks, UK) by the semi-dry blotting method. In brief, 3 sheets of Whatman 
3MM filter paper (Whatman International Ltd, Kent, UK) were soaked in anode buffer 
1 (300 mM Tris, 20% methanol, pH 10.4) and placed on the anode plate. On top of this 
were placed 2 sheets of filter paper soaked in anode buffer 2 (25 mM Tris, 20% 
methanol, pH 10.4). After wetting with methanol, a sheet of PVDF was added to the top 
of the filter papers. The resolving gel was placed on the PVDF and finally, 5 sheets of 
filter paper soaked in cathode buffer (25 mM Tris base, 40 mM 6-amino-n-hexanoic 
acid, 20% methanol, pH 9.4) were placed on top of the resolving gel. The transfer was 
carried out at 40 mA per gel for 45 minutes. After the transfer, the blot was placed in 
blocking buffer (tris buffered saline [TBS] with 3% skimmed milk powder and 0.05% 
polysorbate 20 [Tween-20]) with gentle shaking for one hour at room temperature. 
Primary antibodies were then added and left overnight on a shaker at room temperature. 
The primary antibody rabbit anti-phospho-ezrin (Thr567)/radixin (Thr564)/moesin 
(Thr558) (phos-ERM) (Cell Signalling Technologies, Massachusetts, US) was used at a 
dilution of 1:50 while rabbit anti-radixin (Sigma-Aldrich, Dorset, UK) was used at a 
dilution of 1:100. After washing with TBS buffer and TBS buffer containing 0.05% 
Tween-20, the probed membrane was incubated in alkaline phosphatase conjugated 
secondary antibody at 1:1000 dilution for one hour at room temperature. Following 
further washes with TBS buffer and TBS buffer containing 0.05% Tween-20, the 
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membrane was washed in alkaline phosphatase buffer (0.2 M MgCl2, 0.1 M Tris pH 9.5 
and 0.1 M NaCl) for 5 minutes. Finally the membrane was incubated in 20 ml of 
alkaline phosphatase buffer containing 20 µl of 5-bromo-4 chloro-3-indolyl phosphate 
(BCIP) and 20 µl of nitro-blue tetrazolium chloride (NBT) until the colour developed  
(~ 10 minutes). Washing the membrane several times with deionised water stopped the 
reaction and the membrane was dried on paper towels. 
 
Reagent 10% gel (2 gels) 7.5% gel (2 gels) 
Acrylamide (30% acrylamide, 0.8% 
bis-acrylamide)  
2.66 ml  2 ml 
4x Resolving gel buffer (18.2 g 
Trizma base, 400 mg SDS, pH 8.6) 
2 ml 2 ml 
Ammonium persulphate (5 mg/ml) 0.8 ml 0.8 ml 
Distilled water 2.54 ml 3.2 ml 
TEMED 10 µl 10 µl 
Table 2.2 Resolving gel composition 
 
Reagent For 2 gels 
Acrylamide  0.4 ml 
Distilled water 2.2 ml 
Ammonium persulphate (5 mg/ml) 0.4 ml 
4x stacking Tris buffer (6.65 g Trizma 
base, 400 mg SDS, pH 8.6) 
1 ml 
TEMED  10 µl 
Table 2.3 Stacking gel composition 
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2.15.3 Gel densitometry 
PVDF membranes were scanned using an Epson 1600 Pro scanner, and the grey-scale 
values were measured using ImageJ software. SPSS 16.0 software was used to check 
normality of distribution using the Kolmogorov-Smirnov test, and Excel software was 
used to calculate p values using independent t-tests with equal variances not assumed. 
Excel software was also used to generate histograms from the grey-scale values and to 
calculate mean and standard deviation.  
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3.1 Inhibitors of c-Jun N-terminal kinase have different effects on hair bundle 
structure. 
c-Jun N-terminal kinase (JNK) is a member of the mitogen-activated protein kinase 
(MAPK) family, and is activated by stimuli that cause cell stress, such as ischemia 
(Rincón and Davis, 2009). One result of JNK activation is apoptotic cell death. The 
three JNK inhibitors (JNK inhibitor I, JNK inhibitor II, JNK inhibitor V) used in the 
screen inhibit all known isoforms of JNK.  
Application of 5 µM JNK inhibitor I (IC50 1 µM) for 24 hours caused the elongation and 
collapse of inner hair cell (IHC) stereocilia (Figure 3.1 A) and disrupted a number of 
outer hair cell (OHC) hair bundles (Figure 3.1 A, arrows) in apical coils. In the basal 
coils, damage was more severe, with hair bundles being lost from both the IHCs and 
OHCs, and remaining stereocilia showing elongation and collapse (Figure 3.1 B). JNK 
inhibitor II (IC50 40 nM) at a concentration of 50 µM and JNK inhibitor V (IC50 220 
nM) at a concentration of 2 µM had no effect on hair bundle morphology when applied 
for a 24-hour period under the same conditions (Figure 3.1 C, D, E, F).  
 
3.1.1 The effects of other protein kinase inhibitors range from no effect to hair cell 
death. 
Glycogen synthase kinase-3 (GSK-3) is an enzyme involved in a large number of 
diverse signalling pathways, notably the Wnt signalling pathway that determines cell 
fate in embryonic development, the insulin signalling pathway and the neurotrophic 
pathways (Gould and Manji, 2005). At a concentration of 100 nM, GSK-3 inhibitor 
(IC50 5 nM) had no effect on hair bundle morphology in either apical or basal coils 
(Figure 3.2 A, B) when applied for a 24-hour period.  
 66 
Akt (PKB) is another signalling protein that responds to a wide variety of signals and, 
as a consequence, is involved in many processes such as the regulation of metabolism, 
cell motility and cell-cycle progression (Fayard et al, 2005). A PKB inhibitor, Akt 
inhibitor IV (IC50 625 nM), was used at a concentration of 1 µM for 24 hours, and 
caused severe disruption to the organ of Corti (Figure 3.2 C, D), many hair bundles in 
the apical coil were lost, and where hair bundles remained, stereocilia had collapsed 
haphazardly (Figure 3.2 C). In the basal coil, mainly OHC hair bundles were lost, but 
where hair bundles remained, both IHC and OHC bundles were intact (Figure 3.2 D).  
The Rho family of proteins consists of small GTPases, which, once activated, bind to a 
range of effectors to stimulate signalling downstream (Buchsbaum, 2007). Rho is 
involved in a wide variety of cellular processes including membrane trafficking, 
microtubule stability and actin polymerisation (Schwartz, 2004). Cochlear cultures were 
incubated with 2 mg/ml of C3 Transferase, a Rho A, B and C inhibitor, for 16 hours. 
C3 Transferase showed an indirect effect on hair bundles, localised expansion of the 
luminal surface of the organ of Corti pushed hair bundles out of their normally rigid 
arrangement (Figure 3.2 E, F, arrowheads). Additionally, C3 Transferase also caused 
expansion of the apical surfaces of individual hair cells (Figure 3.2 E, F, arrows). Gross 
hair bundle morphology was, however, unaffected. 
Staurosporine, a broad-spectrum protein kinase inhibitor, has been used in many studies 
as either an inhibitor of protein kinase C or as an inducer of apoptosis (Sakamoto et al, 
1998: Mookherjee et al, 2007: Pérez et al, 2006). At a concentration of 5 nM for 24 
hours, staurosporine caused a consistent “rounding up” of all apical coil OHC hair 
bundles and the frequent elongation of IHC stereocilia with associated collapse (Figure 
3.2 G). In the basal coil, the morphological effect of staurosporine on IHC stereocilia 
was less evident, but OHC stereocilial collapse was uniform (Figure 3.2 H).  
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Controls from apical and basal coils that had been incubated for 24 hours in medium 
containing 0.1% DMSO (Figure 3.3 A, B) or 0.1% water (Figure 3.3 C, D) showed 
normal hair bundle morphology. 
 
3.1.2 Staurosporine causes hair bundle collapse, but specific inhibitors of potential 
staurosporine targets do not have a similar effect. 
To assess which protein kinases staurosporine were targeting to cause the effects seen in 
Figure 3.2 G & H, individual inhibitors against known staurosporine targets (CaM 
kinase II, myosin light chain kinase, PKA, PKC, PKG) were used to treat cochlear 
cultures: inhibitors of Cam kinase II (5 µM of KN 93, Ki 370 nM), myosin light chain 
kinase (10 µM of ML 7, Ki 300 nM), PKCα /βI/δ/ε (1 µM of BIM I: PKCα IC50 0.008 µM, 
PKCβI IC50 0.018 µM, PKCδ IC50 0.21 µM, PKCε IC50 0.132 µM, PKCξ IC50 5.8 µM), 
and PKG (10 µM of KT5823, Ki 234 nM) had no effect on hair bundle morphology 
when applied for a 24-hour period (Figure 3.4 A to H). Inhibition of PKA (10 µM of 
H89, Ki 48 nM) led to disruption of hair bundles in the apical coil, possibly due to the 
enlargement of the apical surfaces of both the inner and outer hair cells (Figure 3.5 A). 
Basal coils were unaffected by H89 treatment (Figure 3.5 B). A cocktail of these 
individual inhibitors (CaM kinase II, myosin light chain kinase, PKA, PKC, PKG) was 
also used to treat cochlear cultures, but staurosporine-like effects on hair bundles were 
not observed (results not shown).  
Other PKC isoforms were inhibited using the PKCθ inhibitor Myr-HQRRGAIKQ 
AKVHHVKC-NH2 and Rottlerin, an inhibitor of PKC δ & θ isoforms (IC50 3-6 µM). At a 
concentration of 40 µM, Myr-HQRRGAIKQ AKVHHVKC-NH2 caused the loss of 
some hair bundles of the inner and outer hair cells in apical coils after 24 hours, 
although bundles that remained were of normal appearance (Figure 3.5 C).  
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In the basal coils, the loss of hair bundles was more severe and few OHC hair bundles 
remained (Figure 3.5 D). After 24 hours, 5 µM Rottlerin caused loss of OHC hair 
bundles in apical coils, as well as loss of IHC and OHC hair bundles in basal coils 
(Figure 3.5 F). Where the OHCs of the apical and basal coils survived, the remaining 
hair bundles appeared to be shorter than the equivalent hair bundles in the 0.1% DMSO 
controls (Figure 3.5 I, J).  
Hence the specific inhibitors of potential staurosporine targets either caused no damage 
to hair cells and hair bundles, or the damage caused did not resemble the type or pattern 
of damage caused by staurosporine, as was the case with PKA, Myr-HQRRGAIKQ 
AKVHHVKC-NH2 and Rottlerin. 
 
3.2 Staurosporine and JNK inhibitor I  
Of the protein kinase inhibitors tested in the initial screen, staurosporine was chosen for 
further study as it had a uniform detrimental effect on hair bundles in both apical and 
basal coils without apparently causing hair cell death. In dose response experiments, a 
concentration of staurosporine as low as 2 nM was sufficient to cause hair bundle 
collapse after 24 hours (Figure 3.6 E, F), however, this was not always repeatable, 
hence staurosporine concentrations of either 5 or 10 nM were used in this set of 
experiments. JNK inhibitor I was also of particular interest due to studies showing the 
oto-protective potential of c-Jun N-terminal kinase inhibition in preventing auditory hair 
cell apoptosis after drug or noise induced trauma (Wang et al, 2003: Coleman et al, 
2007). Therefore in order to gain further insight into the possible mechanism of hair 
bundle damage caused by staurosporine and JNK inhibitor I, cochlear cultures treated 
with these inhibitors were further examined by confocal, transmission and scanning 
electron microscopy. 
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3.2.1 Effects of staurosporine can be first seen by 5 hours 
Hair bundles were unaffected by 2.5 hours of 5 nM staurosporine treatment, but by 5 
hours, basal coil hair bundle collapse was seen using confocal microscopy (Figure 3.7 
D). In order to examine the effects of staurosporine on hair-cell surface morphology in 
more detail, SEM analysis was used. Figure 3.8 shows cochlear cultures treated with 10 
nM staurosporine for 14 hours, apical coil OHC hair bundles have collapsed inwards 
(Figure 3.8 A, C), while the hair bundles of basal coil OHCs have collapsed outwards 
(Figure 3.8 B, D), with the apical surfaces of the hair cells apparently reabsorbing hair 
bundles (Figure 3.8 D, arrows). There is also a marked decrease in the amount of 
supporting cell microvilli in the basal coil (Figure 3.8 B, arrows) in comparison to 
controls (Figure 3.8 F). 
Using transmission electron microscopy, clusters of vesicles were visible that had 
accumulated at the base of the hair bundles after 5 hours of 5 nM staurosporine 
treatment (Figure 3.9 A, B, arrows). Similar clusters were not observed in the controls 
(Figure 3.9 E, F). At 10 hours, apical coil IHC hair bundles remained unaffected by 
staurosporine treatment; however, there is a separation of the cuticular plate from the 
overlying plasma membrane (Figure 3.9 C, double arrows). Basal coil IHC hair bundles 
showed collapse by 10 hours, some possibly having decoupled from their rootlets 
(Figure 3.9 D, arrow), whilst other stereocilia retained largely intact rootlets (Figure 3.9 
D, arrowhead). The separation of the cuticular plate from the overlying plasma 
membrane seen in IHCs at 10 hours were already present by 5 hours in apical coil 
OHCs (Figure 3.10 A, double-headed arrows), as were accumulations of vesicles 
(Figure 3.10 A, single arrows). In basal coil OHCs at 5 hours, the plasma membranes 
were bulging and contained a large number of vesicles (Figure 3.10 B), with possible 
separation of stereocilia from their rootlets (Figure 3.10 B, arrow). By 10 hours, the area 
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that separated the cuticular plate and the plasma membrane had increased in size, and 
caused the elevation of hair bundles away from the cuticular plate (Figure 3.10 C, 
double arrow). In the basal coils, OHC hair bundles had collapsed completely by 10 
hours (Figure 3.10 D, arrowheads), leaving rootlets in the cuticular plate (Figure 3.10 D, 
single arrows). Material accumulated between the cuticular plate and the plasma 
membrane is indicated by the double-headed arrow (Figure 3.10 D). 
 
3.2.2 JNK inhibitor I shows a marked effect on hair bundles. 
Scanning electron microscopy showed that at 14 hours, many hair bundles of the apical 
coil OHCs were intact and normal (Figure 3.11 A, arrowheads). In among these 
apparently undamaged hair bundles though, many OHC hair bundles had collapsed and 
individual stereocilia showed elongation (Figure 3.11 A, C, arrows). Some basal coil 
OHC stereocilia also showed elongation (Figure 3.11 D, arrowhead), but in contrast to 
the apical coil, OHC hair bundles in the basal coil had uniformly collapsed (Figure 3.11 
B, D, arrows). 
JNK inhibitor I caused collapse of apical and basal coil IHC stereocilia by as early as 5 
hours (Figure 3.12 A, B), and by 10 hours collapsed stereocilia were in the process of 
being reabsorbed back into the hair cell (Figure 3.12 C, D, arrows). Basal coil OHC hair 
bundles had also been damaged by 5 hours (Figure 3.13 B), and by 10 hours, hair cells 
had died (Figure 3.13 D). In contrast, apical coil OHC hair bundles had not collapsed at 
5 hours (Figure 3.13 A) and this remained the case at 10 hours, although there was some 
disruption of the cell membrane at the base of hair bundles (Figure 3.13 C, arrow). In 
both apical and basal coils, treatment with JNK inhibitor I resulted in much membrane 
debris seen above the hair bundles (Figure 3.12 A to C and 3.13 A to C). 
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3.2.3 At 8 hours, externalisation of phosphatidylserine was detected in JNK 
inhibitor I, but not staurosporine, treated cultures. 
The translocation of phosphatidylserine from the inner leaflet to the outer leaflet of the 
plasma membrane can be one of the first signs of apoptosis. To ascertain whether JNK 
inhibitor I and staurosporine cause apoptosis in hair cells, cochlear cultures were treated 
with either 5 µM JNK inhibitor I or 10 nM staurosporine for 8 hours before labelling 
with Alexa Fluor 488 annexin V. 
Annexin V labelling was observed in both apical (Figure 3.14 C) and basal (Figure 3.14 
D) coils that had been treated with JNK inhibitor I, but not for either the apical (Figure 
3.14 G) or basal (Figure 3.14 H) coils of staurosporine treated cultures. Over a longer 
period of 48 hours, toluidine blue staining of resin embedded cultures showed that 5 µM 
JNK inhibitor I treated apical coils retained both inner and outer hair cells (Figure 3.15 
A). In the basal coils, IHCs were present, but all three rows of OHCs were missing 
(Figure 3.15 B). At a concentration of 10 nM, staurosporine had no adverse effects on 
the survival of either inner or outer hair cells in the apical and basal coils at 48 hours 
(Figure 3.15 E, F).  
 
3.2.4 JNK inhibitor I–induced phosphatidylserine externalisation is rapid and dose 
dependent. 
To establish the concentration and length of JNK inhibitor I treatment needed to cause 
translocation of phosphatidylserine, dose response experiments were carried out using 
1, 2 and 5 µM JNK inhibitor I for 5 minutes. A JNK inhibitor I concentration of 5 µM 
caused some phosphatidylserine externalisation in apical coils (Figure 3.16 C), with 
increased phosphatidylserine detection in the basal coils (Figure 3.16 D). A 
concentration of 2 µM JNK inhibitor I was also sufficient to cause occasional 
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phosphatidylserine externalisation in apical coils (Figure 3.16 G), with a greater amount 
detected in the basal coils (Figure 3.16 H). No labelling of phosphatidylserine occurred 
at 1 µM JNK inhibitor I for either apical (Figure 3.16 K) or basal (Figure 3.16 L) coils. 
 
3.2.5 Staurosporine treatment does not block neomycin–induced 
phosphatidylserine externalisation.  
The aminoglycoside antibiotic neomycin is known to induce phosphatidylserine 
externalisation in hair cells, and is thought to enter hair cells via their 
mechanotransducer channels (Gale et al, 2001: Marcotti et al, 2005: Goodyear et al, 
2008). In order to assess how staurosporine-induced stereocilia collapse affects 
neomycin-induced phosphatidylserine externalisation, cochlear cultures were treated 
with neomycin in the presence of annexin V after 8 hours of treatment with 10 nM 
staurosporine. Despite the staurosporine-induced hair bundle disruption observed in the 
apical (Figure 3.17 A) and basal (Figure 3.17 B) coils, a robust neomycin–induced 
phosphatidylserine externalisation response was observed in both the apical and the 
basal coils (Figure 3.17 G, H). 
The finding that staurosporine treatment does not eliminate mechanotransducer function 
is supported by the results of FM1-43 loading. FM1-43 is a styryl pyridinium dye that is 
lipophilic, non-toxic, and fluorescent when incorporated into the cell membrane. In the 
inner ear, FM1-43 has been shown to selectively label hair cells (Nishikawa and Sasaki, 
1996: Meyer et al, 2001), although there was uncertainty as to whether FM1-43 enters 
via endocytosis or through the mechanically gated transduction channel situated on the 
tips of the stereocilia. More recent studies indicate that longer incubation times allows 
cell entry via endocytosis while shorter incubation times result in entry via the 
mechanotransduction channels (Gale et al, 2001: Griesinger et al, 2004: Kaneko et al, 
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2006: Meyers et al, 2003). Cochlear cultures treated with 10 nM staurosporine for 10 
hours were exposed to 3 µM FM1-43 for 10 seconds. Both apical and basal coils (Figure 
3.18 C, D) showed FM1-43 loading, but this was reduced in comparison to their 0.1% 
DMSO controls (Figure 3.18 E, F). 
 
3.3 Effects of staurosporine and JNK inhibitor I treatment on the distribution of 
ezrin-radixin-moesin (ERM) proteins. 
While both staurosporine and JNK inhibitor I treatment resulted in collapsed hair 
bundles, staurosporine treatment also caused a reduction in the number of microvilli on 
the apical surfaces of supporting cells (Figure 3.8 B) as well as a separation of the hair 
cell cell membrane from the cuticular plate (Figure 3.9 C, Figure 3.10 A-D). The 
separation of the plasma membrane from the cuticular plate is a feature similar to that 
seen in the OHCs of radixin deficient mice at P21 (Kitajiri et al, 2004). Therefore, the 
presence and distribution of radixin, as well as of phosphorylated ezrin-radixin-moesin 
(phos-ERM) were examined in staurosporine treated cochlear cultures by Western 
blotting and immunofluorescence microscopy.  
JNK is one of the protein kinases potentially activated downstream of the small 
GTPases Rho, Rac and Cdc42 (Yamauchi et al, 2001: Potin et al, 2007), which are 
known to be major binding partners for ERM proteins (Hirao et al, 1996: Kotani et al, 
1997: Matsui et al, 1998). More recently, JNK has also been suggested to have a role in 
the Rho associated kinase (ROCK)-ERM activation pathway during disassembly of 
epithelial junctions (Naydenov et al, 2009). Therefore, to assess whether JNK inhibition 
affected the presence and distribution of radixin and phos-ERM, JNK inhibitor I treated 
cochlear cultures were also examined by Western blotting and immunofluorescence 
microscopy.  
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3.3.1 Staurosporine treatment has no effect on the presence of radixin, but reduces 
the presence of phos-ERM in hair bundles. 
After 16 hours of incubation in 5 nM staurosporine, radixin was still present in both 
apical coil and basal coil inner and outer hair bundles (Figure 3.19 A, E) as well as in 
the microvilli of supporting cells (Figure 3.19 A, E, arrows). The presence of radixin 
was also examined by Western blotting of cochlear cultures incubated with 10 nM 
staurosporine for 1, 2.5, 5, 10 and 14 hours. A representative Western blot for cochlear 
cultures treated with 14 hours of staurosporine and probed for radixin showed no 
difference between the staurosporine treated cultures and the 0.1% DMSO controls 
(Figure 3.20). In contrast to radixin, 14 hours of 10 nM staurosporine treatment resulted 
in greatly attenuated levels of phos-ERM in hair bundles for both apical and basal coils 
(Figure 3.21 B, H, arrows). Additionally, the presence of phos-ERM in the microvilli of 
supporting cells was also greatly attenuated (Figure 3.21 B, H, arrowheads). The 
presence of phos-ERM was also examined by Western blotting of cochlear cultures 
incubated with 10 nM staurosporine for 1, 2.5, 5, 10 and 14 hours. Figure 3.22 shows a 
representative Western blot for cochlear cultures treated with 14 hours of staurosporine 
and probed for phos-ERM, and illustrates a reduction of phos-ERM in staurosporine 
treated cultures in comparison to 0.1% DMSO controls. 
Densitometric analysis of scanned PVDF membranes showed that the radixin grey-scale 
values of staurosporine treated cochlear cultures differed very little from the radixin 
grey-scale values of 0.1% DMSO control cultures over time (Figure 3.23, orange bars). 
This result was supported by statistical analysis of grey-scale values at 14 hours, which 
showed no significant difference (p = 0.70) between radixin values of staurosporine and 
DMSO treated cochlear cultures (Figure 3.23). For phos-ERM, densitometric analysis 
indicated a trend of decreasing grey-scale values against 0.1% DMSO over time, and 
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this was confirmed by statistical analysis at 14 hours which showed a significant 
reduction (p = 0.04) of phos-ERM levels in staurosporine treated cochlear cultures 
against 0.1% DMSO control values (Figure 3.23). 
 
3.3.2 Staurosporine does not affect PIP2 distribution in the hair bundle 
A previous study suggested that levels of PIP2 could be reduced in rat basophilic 
leukemia cells as a result of PKC inhibition by staurosporine (Apgar, 1995). Therefore 
in order to assess whether the attenuation of phos-ERM levels in staurosporine treated 
cochlear cultures was due to an adverse effect of staurosporine on the presence of PIP2, 
cochlear cultures were transfected with the PIP2 reporter PLCδ1PH by gene gun and 
treated with 10 nM staurosporine for 7 hours. The presence and distribution of PIP2 in 
hair cells and hair bundles were unaffected by staurosporine treatment (Figure 3.24 B, 
H) when compared to 0.1% DMSO controls (Figure 3.24 E, K). 
 
3.3.3 JNK inhibitor I treatment has no effect on the presence of either phos-ERM 
or radixin in hair bundles.  
Where hair bundles remained after treatment with 5 µM JNK inhibitor I for 14 hours, 
phos-ERM was present in apical coil hair bundles (Figure 3.25 B, arrows). Anti-phos-
ERM labelling of supporting cell microvilli was present in both apical and basal coils 
(Figure 3.25 B, H, arrowheads). Figure 3.26 shows a representative Western blot for 
cochlear cultures treated with 14 hours of 5 µM JNK inhibitor I and probed for phos-
ERM and radixin. Densitometric analysis of scanned PVDF membranes showed that 
there were no significant differences between either radixin (p = 0.77) or phos-ERM (p 
= 0.77) grey-scale values against their 0.1% water controls (Figure 3.27).  
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3.4 Endocytosis is not adversely affected by staurosporine treatment. 
Staurosporine treatment of cochlear cultures often resulted in the bulging of the hair cell 
apical membrane (Figure 3.10 B, C). To examine whether this bulging was caused by 
the expansion of the apical surface due to a failure in endocytosis, cochlear cultures 
were treated with 10 nM staurosporine for 4 hours at 37 ºC, incubated with cationic 
ferritin for one hour on ice and incubated for a further 4 hours at 37 ºC with 
staurosporine. Transmission electron micrographs showed that the areas beneath the 
bulging membrane contain endocytic vesicles encapsulating cationic ferritin (Figure 
3.28 A, B, arrows), as well as vesicles without cationic ferritin (Figure 3.28 A, B, 
arrowheads). Transmission electron micrographs also showed vesicles containing 
cationic ferritin in the cuticular plates of hair cells in both apical and basal coils of 0.1% 
DMSO controls (Figure 3.28 C, D, arrows). 
 
3.5 Hair bundle recovery 
As it has been shown that auditory hair cells and hair bundles can recover from damage 
under certain conditions (Sobkowicz et al, 1995: Tsuprun et al, 2003: Goodyear et al, 
2008), immature (P1-P2) mouse hair bundles were examined by fluorescent and 
scanning electron microscopy at various time points after brief treatment with either 
staurosporine or neomycin and assessed for signs of hair bundle recovery. 
 
3.5.1 Staurosporine causes irreversible hair-bundle collapse as well as continued 
hair bundle degeneration even after short treatment duration. 
Cochlear cultures were treated with 5 nM staurosporine for 14 hours and returned to 
fresh staurosporine-free media for a further 48 hours (Figure 3.29). OHC hair-bundle 
collapse seen at 14 hours (Figure 3.29 A, B) remained after 48 hours (Figure 3.29 C, D), 
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and IHC hair bundles, which showed little damage at 14 hours (Figure 3.29 A, B), had 
collapsed after 48 hours (Figure 3.29 C, D), indicating no recovery of normal hair 
bundle morphology for the hair bundles of either inner or outer hair cells. 
Even where a short duration of 10 nM staurosporine treatment caused no visible hair 
bundle damage at an early time point of 2.5 hours (Figure 3.30 A, B), return to fresh 
staurosporine-free media for 7.5 hours resulted in collapse of OHC hair bundles from 
both apical and basal coils (Figure 3.30 C, D). Hair bundle deterioration continued 
though the 24-hour recovery period (Figure 3.30 E, F) and by 48 hours, some collapsed 
apical and basal coil OHC hair bundles also showed elongated stereocilia (Figure 3.30 
G, H, arrows). 
 
3.5.2 Hair cells show some recovery from blebbing caused by neomycin, but hair 
bundles do not recover from 1, 2 or 4 hours of neomycin treatment. 
Using basal coil cochlear cultures, 1 hour of treatment with 1 mM neomycin at 23 °C 
caused blebbing on the surface of the hair cell (Figure 3.31 A). Some blebs appeared to 
be associated with the hair bundles (Figure 3.31 A, arrows), while others were not 
(Figure 3.31 A, arrowheads). When neomycin was removed after 1 hour and the 
cochlear cultures placed in neomycin-free media for a further 23 hours at 37 °C, 
blebbing had reduced, but many mid sections of the hair bundles were missing (Figure 
3.31 B, arrows) and the density of supporting cell microvilli appeared reduced (Figure 
3.31 B, arrowheads).  
Cochlear cultures incubated for 2 hours with 1 mM neomycin at 23 °C showed some 
surface blebbing (Figure 3.32 A, arrows). After 22 hours recovery time in media at 37 
°C, blebs and hair bundle degeneration remained visible (Figure 3.32 B, arrows).  
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Some hair cells also appeared to be in the process of being extruded (Figure 3.32 B, 
arrowheads). 
After 4 hours of 1 mM neomycin incubation at 23 °C, there were a few hair bundles that 
appeared to be normal (Figure 3.33 A, arrows), but many showed signs of degeneration 
(Figure 3.33 A, right angle arrows). Numerous small blebs resided on the surface of the 
cochlear culture, but very large blebs were also present (Figure 3.33 A, arrowheads), 
and some cells were in the process of being extruded (Figure 3.33 A, bendy arrows). 
After 20 hours recovery, intact IHC hair bundles were still visible (Figure 3.33 B, 
arrows). However, no OHC hair bundles were observed, and there was a band of debris 
above the position where the OHCs would normally be situated (Figure 3.33 B, 
arrowheads). 
 
3.5.3 A lower concentration of 10 µM neomycin caused no hair bundle loss after 3 
days, but hair bundles were eventually lost even after cessation of neomycin 
treatment. 
In studies where neomycin has been used to cause damage or degeneration to 
mammalian auditory or vestibular hair cells, the typical concentration of neomycin used 
was 1 mM (Zine and de Ribaupierre, 1998: Quint et al, 1998: Gale et al, 2001). To 
assess the effect of a lower concentration of neomycin over a number of days, cochlear 
cultures were incubated with 10 µM neomycin for 72 hours at 37 °C. 
When cochlear cultures were fixed and examined after 72 hours in neomycin, neither 
apical or basal coil hair bundles showed any sign of morphological damage (Figure 3.34 
A, B). However, when neomycin was removed and the cochlear cultures were incubated 
in fresh neomycin-free media for a further 72 hours, both inner and outer hair cells of 
the apical coil showed disrupted hair bundles (Figure 3.34 C). In the basal coil, IHC hair 
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bundles were still intact, but no OHC hair bundles remained (Figure 3.34 D). As hair 
bundles were undamaged after 72 hours of incubation with neomycin, but were lost 
after a further 72 hours in neomycin-free medium, hair cell viability was assessed after 
24 and 72 hours in 10 µM neomycin by dipping in propidium iodide. Propidium iodide 
(PI) is a nucleic acid stain that is impermeant and normally excluded from viable cells. 
After 24 hours neomycin treatment, hair cells remained impermeable to PI (Figure 3.35 
C), but after 72 hours, there was clear PI uptake by the OHCs (Figure 3.35 D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 3.1 Confocal images of phalloidin stained cochlear cultures treated with 
JNK inhibitor I, JNK inhibitor II and JNK inhibitor V for 24 hours. Apical (A, C, 
E) and basal (B, D, F) coil cochlear cultures incubated with 5 µM JNK inhibitor I (A, 
B), 50 µM JNK inhibitor II (C, E), 2 µM JNK inhibitor V (E, F). Arrows indicate 
disruption to apical OHC hair bundles. Scale bar = 10 µm. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Confocal images of phalloidin stained cochlear cultures treated with 
protein kinase inhibitors. Apical (A, C, E, G) and basal (B, D, F, H) coil cochlear 
cultures incubated with 100 nM GSK 3 for 24 hours (A, B), 1µM Akt IV for 24 hours 
(C, D), 2 mg/ml C3 transferase for 16 hours (E, F) and 10 nM staurosporine for 24 
hours (G, H). Arrows and arrowheads (E, F) indicate expanded apical surfaces of hair 
cells (arrows) and supporting cells (arrowheads). Scale bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 Figure 3.3 Confocal images of control phalloidin-stained cochlear cultures. Apical 
(A, C) and basal (B, D) region cochlear cultures incubated with medium containing 
0.1% DMSO (A, B) or 0.1% water (C, D) for 24 hours. Scale bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Confocal images of phalloidin-stained cochlear cultures treated with 
specific inhibitors of potential staurosporine targets for 24 hours. Apical (A, C, E, 
G) and basal (B, D, F, H) coil cochlear cultures treated with 5 µM KN93 (A, B), 10 µM 
ML7 (C, D), 1 µM BIM I (E, F) and 10 µM KT5823 (G, H). Apical (I) and basal (J) coil 
cochlear cultures incubated with medium containing 0.1% DMSO as controls. Scale bar 
= 10 µm. 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Confocal images of phalloidin-stained cochlear cultures treated with 
potential PKC staurosporine targets for 24 hours. Apical (A, C, E) and basal (B, D, 
F) coil cochlear cultures incubated with 10 µM H89 (A, B), 40 µM PKCθ inhibitor 
(Myr-HQRRGAIKQ AKV HHVKC-NH2) (C, D) and 5 µM Rottlerin (E, F). Apical (G, 
I) and basal (H, J) coil cochlear cultures incubated with medium containing 0.1% water 
(G, H) and 0.1% DMSO (I, J) as controls. Scale bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Confocal images of phalloidin-stained cochlear cultures treated with 
different staurosporine concentrations for 24 hours. Apical (A, C, E) and basal (B, 
D, F) coil cochlear cultures incubated with 10 nM staurosporine (A, B), 5 nM 
staurosporine (C, D), 2 nM staurosporine (E, F) for 24 hours. Apical (G) and basal (H) 
coil cochlear cultures incubated with medium containing 0.1% DMSO for 24 hours. 
Scale bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
Figure 3.7 Confocal images of phalloidin-stained cochlear cultures treated with 5 
nM staurosporine for 2.5, 5 and 10 hours. Apical (A, C, E) and basal (B, D, F) coil 
cochlear cultures treated with 5 nM staurosporine for 2.5 hours (A, B), 5 hours (C, D) 
and 10 hours (E, F). Apical (G) and basal (H) coil cochlear cultures incubated with 
medium containing 0.1% DMSO for 10 hours. Scale bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
Figure 3.8 Scanning electron micrographs of P2 mouse auditory hair cells after 
treatment with 10 nM staurosporine for 14 hours. Apical (A, C, E) and basal coil (B, 
D, F) cochlear cultures treated with 10 nM staurosporine (A, B, C, D) and medium 
containing 0.1 % DMSO control (E, F). Staurosporine treated apical (C) and basal (D) 
coil outer hair cells shown at higher magnification. Panel B arrows indicates the paucity 
of supporting cell microvilli, and panel D arrows show hair bundle bases being 
reabsorbed back into hair cell apical surfaces. Scale bars = 0.5 µm, 2 µm. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Transmission electron micrographs of P2 mouse auditory inner hair 
cells after treatment with 5 nM staurosporine for 5 or 10 hours. Apical (A, C) coil 
inner hair cells treated with 5 nM staurosporine for 5 hours (A) or 10 hours (C). Basal 
(B, D) coil inner hair cells treated with 5 nM staurosporine for 5 hours (B) or 10 hours 
(D). Apical (E) and basal coil (F) inner hair cells incubated with medium containing 
0.1% DMSO control for 10 hours. Panel A and B arrows indicate accumulation of 
vesicles. In panel C, double-headed arrows indicate a separation of the cuticular plate 
from the overlying plasma membrane and in panel D, the arrow shows an isolated 
rootlet, and the arrowhead shows an intact rootlet. Scale bar = 0.5 µm 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Transmission electron micrographs of P2 mouse auditory outer hair 
cells after treatment with 5 nM staurosporine for 5 or 10 hours. Apical (A, C) coil 
outer hair cells incubated with 5 nM staurosporine for 5 hours (A) and 10 hours (C). 
Basal (B, D) coil outer hair cells incubated with 5 nM staurosporine for 5 hours (B) and 
10 hours (D). Apical (E) and basal coil (F) outer hair cells incubated with medium 
containing 0.1% DMSO control for 10 hours. Panel A, C and D double-headed arrows 
indicate a separation of the cuticular plate from the overlying plasma membrane, and 
panel A single arrows show vesicles in the cuticular plate. Panel B and D single arrows 
shows isolated rootlets. Panel D arrowheads indicate hair bundle collapse. Scale bar = 
0.5 µm 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.11 Scanning electron micrographs illustrating the effect of JNK inhibitor 
I on mouse cochlear cultures at 14 hours. Apical (A, C, E) and basal coil (B, D, F) 
cochlear cultures incubated with 5 µM JNK inhibitor I (A, B, C, D) or in medium 
containing 0.1% JNK inhibitor I negative control (E, F). JNK inhibitor I treated apical 
(C) and basal (D) coil outer hair cells shown at higher magnification. Arrowheads in 
panel A indicate apparently normal hair bundles and arrows in panel A and C show hair 
bundle collapse and elongation. Arrows in panel B and D show hair-bundle collapse and 
arrowhead in panel D shows stereocilia elongation. Scale bars = 0.5 µm, 2 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.12 Transmission electron micrographs of P2 mouse auditory inner hair 
cells after treatment with 5 µM JNK inhibitor I for 5 and 10 hours. Apical (A, C) 
coil inner hair cells treated with 5 µM JNK inhibitor I for 5 hours (A) and 10 hours (C). 
Basal (B, D) coil inner hair cells incubated with 5 µM JNK inhibitor I for 5 hours (B) 
and 10 hours (D). Apical (E) and basal coil (F) inner hair cells incubated with medium 
containing 0.1% water control for 10 hours. Arrows in panels C and D indicates re-
absorption of stereocilia back into hair cells. Scale bar = 0.5 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.13 Transmission electron micrographs of P2 mouse auditory outer hair 
cells after treatment with 5 µM JNK inhibitor I for 5 and 10 hours. Apical (A, C) 
coil outer hair cells treated with 5 µM JNK inhibitor I for 5 hours (A) and 10 hours (C). 
Basal (B, D) coil outer hair cells treated with 5 µM JNK inhibitor I for 5 hours (B) and 
10 hours (D). Apical (E) and basal (F) coil outer hair cells incubated with medium 
containing 0.1% water control for 10 hours. Panel C arrow indicates disruption of 
plasma membrane at the base of the stereocilia. Scale bar = 0.5 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 3.14 Annexin V detection of phosphatidylserine externalization in JNK 
inhibitor I and staurosporine treated cochlear cultures. Normarski interference 
contrast (A, B, E, F, I, J) and fluorescent (C, D, G, H, K, L) images of apical (A, C, E, 
G, I, K) and basal (B, D, F, H, J, L)  coil cultures treated for 8 hours with 5 µM JNK 
inhibitor I (A-D), 10 nM staurosporine (E-H) and medium containing 0.1% DMSO (I-
L) as control and imaged 5 minutes after onset of annexin V labelling.  
Scale bar = 50 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
Figure 3.15 Toluidine blue staining showing the effect of JNK inhibitor I and 
staurosporine on mouse cochlear cultures at 48 hours. Apical (A, C, E, G) and basal 
coil (B, D, F, H) cochlear cultures treated with 5 µM JNK inhibitor I (A, B), 5 µM JNK 
inhibitor I negative control (C, D), 10 nM staurosporine (E, F) and medium containing 
0.1% DMSO as a control (G, H). Scale bar = 10µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 3.16 Annexin V detection of phosphatidylserine externalization in cochlear 
cultures treated with different concentrations of JNK inhibitor I for 10 minutes at 
room temperature. Normarski interference contrast (A, B, E, F, I, J) and fluorescent 
(C, D, G, H, K, L) images of apical (A, C, E, G, I, K) and basal (B, D, F, H, J, L)  coil 
cultures treated for 8 hours with 5 µM JNK inhibitor I (A-D), 2 µM JNK inhibitor I (E-
H) and 1 µM JNK inhibitor I (I-L), for 5 minutes prior to imaging. Scale bar = 50 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
Figure 3.17 Annexin V detection of phosphatidylserine externalization in 
staurosporine treated cochlear cultures. Normarski interference contrast (A, B, E, F) 
and fluorescent (C, D, G, H) images of apical (A, C, E, G) and basal (B, D, F, H)  coil 
cultures treated with 10 nM staurosporine for 8 hours and imaged before (A-D) and 5 
minutes after (E-H) treatment with 2 mM neomycin. Scale bar = 50 µm. 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 3.18 FM1-43 loading in staurosporine treated cultures. Apical (A, C, E, G) 
and basal coil (B, D, F, H) cochlear cultures treated with 10 nM staurosporine (A, B, C, 
D) or medium containing 0.1% DMSO as a control (E, F, G, H) for 10 hours and dipped 
in 3 µM FM1-43 (C, D, E F). Confocal scale bar = 10 µm, fluorescence scale bar = 50 
µm. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.19 Confocal images of phalloidin stained cochlear cultures treated with 5 
nM staurosporine for 16 hrs and labelled with anti-radixin antibody. Apical (A, C) 
and basal coil (E, G) cochlear cultures incubated with 5 nM staurosporine (A, E) and 
medium containing 0.1% DMSO (C, G) as a control, and labelled with anti-radixin 
antibody. Counterstaining with phalloidin (B, D, F, H). Arrows in panel A and E 
indicate radixin labelling of supporting cell microvilli. Scale bar = 5 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
Figure 3.20 Western blotting of cochlear cultures for radixin 
after 14 hours of staurosporine treatment. Immuno-detection of  
radixin after 14 hours of 10 nM staurosporine treatment. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.21 Confocal images of phalloidin stained cochlear cultures treated with 10 
nM staurosporine for 14 hrs and labelled with anti-phospho-ERM monoclonal 
antibody. Apical (B, E) and basal (H, K) coil cochlear cultures treated with 10 nM 
staurosporine (B, H) or medium containing 0.1% DMSO as a control (E, K), and 
labelled with anti-phospho-ERM monoclonal antibody. Counterstaining with phalloidin 
(A, D, G, J). Arrows in panels B and H indicate attenuated phos-ERM levels in hair 
bundles, and arrowheads show attenuated phos-ERM levels in the microvilli of 
supporting cells. Scale bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
Figure 3.22 Western blotting of cochlear cultures for phos-ERM after  
14 hours of staurosporine treatment. Immuno-detection of phos-ERM  
after 14 hours of 10 nM staurosporine treatment. 
 
 
 
 
  
 
 
 
 
 
 
Figure 3.23 Histograms showing levels of radixin and phos-ERM in immunoblots 
of staurosporine treated cochlear cultures as a percentage of the DMSO control at 
different time points. Densitometry analysis of radixin (orange bars) and phos-ERM 
(purple bars) grey-scale values after 1 hour, 2.5 hours, 5 hours, 10 hours and 14 hours 
treatment with 10 nM staurosporine vs. medium containing 0.1% DMSO as a control. 
At 14 hours, radixin values show no significant difference between staurosporine and 
0.1 % DMSO treated cochlear cultures (p = 0.70), while phos-ERM values do show a 
significant difference between staurosporine and medium containing 0.1% DMSO 
treated cochlear cultures (p = 0.04). 
 
 
  
 
Figure 3.24 Confocal images of phalloidin stained cochlear cultures transfected  
with the PIP2 reporter PLCδ1PH and treated with 10 nM staurosporine for 7  
hours. Apical (B, E) and basal region (H, K) cochlear hair cells transfected with the  
PIP2 reporter PLCδ1PH by gene gun and treated with 10 nM staurosporine (B, H) or 
medium containing 0.1% DMSO as a control (E, K) for 7 hours. Counterstaining 
with phalloidin (A, D, G, J). Scale bar = 10 µm. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.25 Confocal images of phalloidin stained cochlear cultures treated with 5 
µM JNK inhibitor I for 14 hrs and labelled with anti-phospho-ERM monoclonal 
antibody. Apical (B, E) and basal (H, K) coil cochlear cultures treated with 5 µM JNK 
inhibitor I (B, H) or medium containing 0.1% water as a control (E, K), and labelled 
with anti-phospho-ERM monoclonal antibody. Counterstaining with phalloidin (A, D, 
G, J). Arrows in panel B indicates phos-ERM labelling of hair bundles. Panel B and H 
arrowheads indicates phos-ERM labelling of supporting cell microvilli. Scale bar = 10 
µm. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.26 Western blotting of cochlear cultures for phos-ERM  
and radixin after 14 hours of JNK inhibitor I treatment.  
Immuno-detection of phos-ERM and radixin after 14 hours of 5 µM JNK 
inhibitor I treatment. 
 
 
 
 
 
 
 
  
 
 
 
Figure 3.27 Histograms showing levels of radixin and phos-ERM in immunoblots 
of JNK inhibitor I treated cochlear cultures as a percentage of the control at 14 
hours. Densitometry analysis of radixin (orange bar) and phos-ERM (purple bar) grey-
scale values after 14 hours treatment with 5 µM JNK inhibitor I and medium containing 
0.1% water as a control. At 14 hours, neither radixin nor phos-ERM values shows any 
significant differences between JNK inhibitor I and medium containing 0.1% water 
control treated cochlear cultures (p = 0.77). 
 
 
 
  
 
Figure 3.28 Cationic ferritin labelling of staurosporine treated cultures. Apical (A, 
C) and basal region (B, D) cochlear cultures treated with 10 nM staurosporine (A, B) or 
medium containing 0.1% DMSO (C, D) for 4 hours, then with ferritin for 1 hour, 
followed by a further 4 hours with 10 nM staurosporine (A, B) or medium containing 
0.1% DMSO (C, D). Arrows in panels A, B, C and D shows vesicles containing cationic 
ferritin and arrowheads in panels A and B indicate empty vesicles. Insets for all panels 
magnified at x2.5. Scale bar = 0.2 µm. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.29 Confocal images of phalloidin stained cochlear cultures treated with 
staurosporine for 14 hours and allowed to recover for 48 hours. Apical (A, C) and 
basal coil (B, D) cochlear cultures that were treated with 5 nM staurosporine for 14 
hours and either fixed immediately (A, B) or allowed to recover for 48 hours and then 
fixed (C, D). Apical (E) and basal coil (F) cochlear cultures treated with medium 
containing 0.1% DMSO control for 14 hours and allowed to recover for 48 hours. Scale 
bar = 10 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
Figure 3.30 Confocal images of phalloidin stained cochlear cultures treated with 
staurosporine for 2.5 hours and allowed to recover for 7.5, 24 or 48 hours. 
Apical (A, C, E, G) and basal coil (B, D, F, H) cochlear cultures that were treated with 
10 nM staurosporine for 2.5 hours (A, B) and then allowed to recover for 7.5 hours (C, 
D), 24 hours (E, F) and 48 hours (G, H). Apical (I) and basal coil (J) cochlear cultures 
treated with medium containing 0.1% DMSO as controls for 2.5 hours and allowed to 
recover for 48 hours. Arrows in panels G and H indicate elongated stereocilia. Scale bar 
= 10 µm 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
Figure 3.31 Scanning electron micrographs showing basal cochlear cultures 
treated with 1 mM neomycin for 1 hour and allowed to recover for 23 hours. Basal 
coil cochlear cultures treated with 1 mM neomycin in media at 23 ˚C for 1 hour (A, B), 
and allowed to recover for 23 hours at 37 ˚C (B). Basal coil cochlear cultures treated 
with medium supplemented with 0.1% HBHBSS as a control at 23 ˚C for 1 hour and 
allowed to recover for 23 hours at 37 ˚C (C). Arrows in panel A shows hair bundle 
associated blebs, and arrowheads shows blebs not associated with hair bundles. Arrows 
in panel B shows disrupted hair bundles, while arrowheads show a reduction in the 
density of supporting cell microvilli. Scale bar = 2 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
Figure 3.32 Scanning electron micrographs showing basal cochlear cultures 
treated with 1 mM neomycin for 2 hours and allowed to recover for 22 hours. 
Basal coil cochlear cultures treated with 1 mM neomycin in media at 23 ˚C for 2 hours 
(A, B), and allowed to recover for 22 hours at 37 ˚C (B). Basal coil cochlear cultures 
treated with medium supplemented with 0.1% HBHBSS as a control at 23 ˚C for 2 
hours and allowed to recover for 22 hours at 37 ˚C (C). Arrows in panel A shows the 
presence of blebs. Arrows in panel B shows hair bundle disruption, while arrowheads 
shows possible hair cell extrusions. Scale bar = 2 µm. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
Figure 3.33 Scanning electron micrographs showing basal cochlear cultures 
treated with 1 mM neomycin for 4 hours and allowed to recover for 20 hours. 
Basal coil cochlear cultures treated with 1 mM neomycin in media at 23 ˚C for 4 hours 
(A, B), and allowed to recover for 20 hours at 37 ˚C (B). Basal coil cochlear cultures 
treated with medium supplemented with 0.1% HBHBSS control at 23 ˚C for 4 hours 
and allowed to recover for 20 hours at 37 ˚C (C). Panel A arrows: straight arrows 
indicates normal hair bundles, right-angle arrows indicates degenerating hair bundles, 
arrowheads shows the presence of large blebs and bendy arrows shows hair cells 
possibly being extruded. Arrows in panel B shows the presence of IHC hair bundles and 
the arrowheads show debris on the organ of Corti surface. Scale bar = 2 µm. 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
Figure 3.34 Fluorescent images of phalloidin stained cochlear cultures treated 
with 10 µM neomycin for 3 days and allowed to recover for a further 3 days. 
Apical (A, C) and basal region (B, D) cochlear cultures treated with 10 µM 
neomycin for 3 days (A, B) and allowed to recover for a further 3 days in 
neomycin-free media (C, D). Apical (E, G) and basal coil (F, H) cochlear cultures 
incubated with medium supplemented with 0.1 % HBHBSS control for 3 days (E, 
F) or for 6 days (G, H). Scale bar = 10 µm. 
 
 
 
  
 
 
 
 
 
 
 
Figure 3.35 Light and fluorescent images of cochlear cultures incubated with 10 
µM neomycin for 1 and 3 days prior to exposure to propidium iodide, n = 1. Basal 
cochlear cultures treated with 10 µM neomycin for 1 (A) and 3 (B) days, then dipped in 
propidium iodide (C, D). Scale bar = 50 µm. 
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The key findings of this study are: 
1) At low concentrations, staurosporine causes irreparable damage to auditory hair 
bundles but is not lethal to hair cells. 
2) Staurosporine may cause hair bundle damage by affecting the functions of the phos-
ERM proteins. 
3) JNK inhibitor I (L-JNKI-I) is toxic to auditory hair cells. 
4) Hair cells can recover from blebbing caused by neomycin treatment, but hair bundles 
show no recovery. 
 
4.1 Staurosporine 
Staurosporine is a microbial alkaloid first isolated in 1977 (Ōmura et al, 1977), and 
although initially described as a highly potent protein kinase C (PKC) inhibitor with 
IC50 values in the low nanomolar range (Tamaoki et al, 1986), it has since been shown 
to be a broad spectrum, ATP-competitive inhibitor of protein kinases with IC50 values 
varying from nanomolar to micro-molar concentrations depending on the protein kinase 
inhibited (Meggio et al, 1995). The broad spectrum of staurosporine activity may be due 
to its ability to cause induced-fit structural changes to protein kinase ATP-binding sites; 
furthermore, this induced-fit results in tight binding due to multiple non-covalent bonds, 
possibly explaining the low IC50 values that staurosporine can achieve with some 
protein kinases (Prade et al, 1997: Kinoshita et al, 2006: Nakano and Ōmura, 2009).  
A widespread interest in staurosporine stems from its ability to induce most mammalian 
cell types to go into apoptosis (Stepczynska et al, 2001), leading to possible new anti-
cancer treatments (Sánchez et al, 2006: Janosik et al, 2008: Olano et al, 2009). 
However, the mechanism of staurosporine-induced apoptosis has yet to be fully 
elucidated, though it appears that staurosporine utilises both the mitochondrial 
 - 82 - 
cytochrome c release pathway, and also directly activates Caspases 3 and 6 (Zhang et al, 
1998: Chae et al, 2000: Belmokhtar et al, 2001: Gil et al, 2003). In addition to its 
common use in experiments to induce apoptosis, the low IC50 value of staurosporine 
against PKC means that staurosporine has a potential range of effects on the actin 
cytoskeleton through PKC inhibition (Pérez et al, 2006: Hoben and Athanasiou, 2008). 
In this set of experiments, staurosporine was used for the assessment of protein kinase 
inhibition in auditory hair cells and not for the induction of apoptosis. Hence in order to 
identify the most appropriate staurosporine concentration to be used, we examined 
previous studies that investigated staurosporine effects on auditory hair cells. Of the few 
studies that have used staurosporine for inhibiting protein kinases in OHCs, the range of 
concentrations used varied from 10 nM to 1 µM (Puschner and Schacht, 1997: Kakehata 
et al, 1995). Puschner and Schacht (1997) used 10 nM for 30 minutes to assess the 
effect of protein kinase inhibition on calmodulin-dependent protein kinase mediation of 
calcium-induced OHC motility, while Kakehata et al (1995) used 1 µM for 4-8 minutes 
to assess the effect of staurosporine on the neuropeptide substance P, which suppresses 
non-selective cation conductance in the OHC lateral walls. In this current study, a series 
of 24-hour dose response experiments showed that 5 -10 nM staurosporine treatment 
resulted in consistent inner and outer hair cell hair bundle damage with no concomitant 
hair cell loss.  
 
4.1.1 Identifying the staurosporine target needed for maintenance of hair bundle 
structure. 
To begin elucidating the mechanisms underlying staurosporine-induced damage of hair 
bundles, cochlear cultures were incubated with specific inhibitors of known 
staurosporine targets (CaM kinase II, myosin light chain kinase, PKA, PKC, PKG) 
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alone, or together as a protein kinase inhibitor cocktail. Cam kinase II, a ~ 540 kDa 
protein, is made up of multiple subunits (Yamauchi, 2005), and has been shown to bind 
and stabilise F-actin in neurons (Okamoto et al, 2007: Lin and Redmond, 2008). Cam 
kinase II is also thought to have a role in increasing OHC motility in response to 
elevated intracellular calcium (Sziklai et al, 2001). Myosin light chain kinases are 
calmodulin-dependent protein kinases, which phosphorylate the myosin regulatory light 
chain of the myosin II molecule, thus initiating interaction with actin and subsequent 
muscle contraction (Takashima, 2009). Although myosin light chain kinase has been 
localised to the cuticular plate of the OHCs (Jamesdaniel et al, 2009), its precise role 
has yet to be elucidated. Within the OHC, PKG has been implicated in a nitric oxide 
negative feedback loop that regulates ATP-induced intracellular calcium levels (Shen et 
al, 2005).  
Despite these associations with auditory hair cells, our findings showed that inhibition 
of CaM kinase II, myosin light chain kinase and PKG had no effect on hair bundle 
morphology. PKA inhibition did not affect the cochlear basal region at all while causing 
the apical surfaces of both the inner and outer hair cells in the apical region of the 
cochlea to expand, presumably leading to hair bundle damage as a secondary effect. 
This apical region-only effect of PKA inhibition is unusual, as many studies of 
ototoxicity show a base-to-apical gradient where damage and hearing loss occurs first, 
and sometimes only, in the high-frequency basal region of the cochlea (Crofton et al, 
1994: Löwenheim et al, 1999b: Plontke et al, 2007). Perhaps damage to the apical, but 
not the basal, cochlear regions indicate that the action of PKA is dependent on hair-
bundle maturity, with the earlier maturing basal region hair bundles being unaffected by 
PKA inhibition. 
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4.1.2 Staurosporine is unlikely to act through inhibition of PKC. 
There are currently 10 known isoforms of PKC (Roffey et al, 2009), and as the IC50 
value of staurosporine for PKC is low at 0.7 nM, the PKC inhibitor BIM1 was 
anticipated to cause some hair-bundle damage akin to that seen for staurosporine. At  
1 µM, BIM 1 inhibits 4 PKC isoforms (PKCα, PKCβI, PKCδ and PKCε), but in our 
current set of experiments, no hair-bundle damage was seen. Rottlerin, reportedly a 
PKCδ and PKCθ specific inhibitor, caused some hair-cell loss as well as possible 
shortening of the surviving hair bundles.The PKCθ specific inhibitor, the myristoylated 
PKCθ pseudosubstrate sequence peptide Myr-LHQRRGAIKQAKVHHV KC-NH2, 
primarily caused hair-cell loss although normal hair bundles were seen on the remaining 
hair cells. 
There is an inconsistency in these results though, as BIM1 inhibits PKCδ but caused no 
hair-bundle damage, the detrimental effects on hair bundles caused by Rottlerin may not 
be through PKCδ inhibition, but via PKCθ inhibition. However, the damage caused by 
Myr-LHQRRGAIKQAKVHHVKC-NH2 and Rottlerin are very different. 
This discrepancy we observed between Rottlerin and the other PKC inhibitors tested 
may perhaps be due a lack of PKCδ specificity for Rottlerin despite it being widely used 
as a PKCδ inhibitor. Davies et al (2000) tested the inhibitory actions of Rottlerin against 
a range of protein kinases and found that it did not inhibit PKCδ, although it did inhibit 
many other protein kinases. The suggestion that Rottlerin could act through PKCδ 
independent pathways or has multiple targets were supported by other studies that 
showed Rottlerin exerted inhibitory effects even where PKCδ expression had been 
suppressed, or in cells from PKCδ null mice (Leitges et al, 2001: Kayali et al, 2002: 
Zhao et al, 2002). Other studies have suggested that Rottlerin could mimic the effects of 
PKCδ inhibition by direct action on mitochondria (Soltoff, 2001: Kurosu et al, 2007).  
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Hence none of the three PKC inhibitors used in our set of experiments reproduced the 
morphological effect of staurosporine on hair bundles. 
Attempting to identify which potential staurosporine protein kinase target causes the 
hair-bundle damage seen in hair cells may be a lengthy process. When the inhibitory 
effect of staurosporine was tested against 235 protein kinases, it showed IC50 values for 
over 50 protein kinases in the nanomolar range (Nakano and Ōmura, 2009). Hence even 
with the efforts made here to narrow down the range of protein kinases responsible for 
hair-bundle damage, given the broad-spectrum nature of staurosporine activity, there are 
many more protein kinases, and combinations thereof, that remain to be investigated. 
 
4.1.3 Intracellular features of staurosporine treatment. 
4.1.3.1 Bulging of the apical plasma membrane may have caused hair bundle 
collapse. 
Our TEM examination showed staurosporine treated hair cells had a bulging apical 
plasma membrane separated from the cuticular plate by the presence of vesicles and 
cytoplasmic materials. Under normal circumstances, the attachment of the apical 
membrane to both the stereocilia and the cuticular plate contributes to the mechanical 
properties of the hair bundle (Hirokawa and Tilney, 1982), hence it is possible that the 
bulging we observed caused hair bundle collapse in staurosporine treated hair cells.  
This phenomenon of the bulging apical plasma membrane resulting from staurosporine 
treatment differs from the hair bundle damage caused by noise seen in other studies. 
When rabbit and cat auditory hair bundles were subjected to noise exposure, both 
showed hair bundle collapse and formation of giant stereocilia. However, there was no 
separation of the plasma membrane from the cuticular plate, and the most common 
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stereocilia pathology was breaking of the stereocilia at the ankle where the rootlet enters 
the cuticular plate (Engström et al, 1983: Liberman, 1987).  
 
4.1.3.2 Staurosporine does not affect endocytosis at the hair cell apical surface. 
As staurosporine caused the plasma membrane to bulge, we proposed a hypothesis that 
this bulging might have been caused by a reduction in the rate of endocytosis compared 
to the rate of exocytosis. However, application of cationic ferritin showed that endocytic 
vesicles were present beneath the rucked plasma membrane suggesting that endocytosis 
has not been inhibited, although a reduction in the rate of endocytosis is still possible.  
An interesting feature of this result is the demonstration of endocytosis within the area 
of the base of the hair bundle. In other studies of endocytosis in the auditory hair cells 
of adult guinea pigs, it has been shown that for IHCs, endocytosis occurs primarily in 
the pericuticular zone with endocytic vesicles being transported by an infracuticular 
system (Griesinger et al, 2004). In OHCs, the site of endocytosis is reported to be very 
specifically in the area corresponding to the basal body of the kinocilium (Griesinger et 
al, 2004), with vesicles subsequently collecting beneath the cuticular plate (Meyer et al, 
2001). In our experiments, given that in staurosporine treated cells there is a separation 
of plasma membrane from the cuticular plate, it is plausible that on separation, the 
plasma membrane is “released” and able to perform endocytosis. However, it should be 
noted that vesicles containing ferritin were also occasionally seen in control cultures. It 
is possible that the age of the cultures used could affect the location of the apical 
endocytic vesicles in control cultures. This is illustrated by the observation of a large 
numbers of vesicles beneath the apical surfaces of early post-natal mice (P1-P2) basal 
region hair cells by Forge and Richardson (1993), although in both this study and the 
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current set of experiments, the potential for vesicles resulting from cultural artefacts 
cannot be excluded. 
 
4.1.4 Staurosporine and the ERM proteins. 
The distinctive separation of the plasma membrane with the presence of vesicles under 
the hair bundle and rootlet disruption seen in our results was extremely similar to that 
seen in the OHCs of radixin deficient mice at P21 (Kitajiri et al, 2004) (Figure 4.1), 
suggesting that staurosporine action might involve ERM proteins.  
 
 
Figure 4.1 Hair cell stereocilia from P21 radixin null mice, adapted from Kitajiri et al (2004).  
 
The ERM proteins are a highly conserved group of plasma membrane-to-cytoskeleton 
cross-linking proteins belonging to the band 4.1 superfamily, which share a ~ 300 
amino acid common region called a FERM (Four point one Ezrin, Radixin, Moesin) 
domain (Louvet-Vallée, 2000). The FERM domain is situated at the membrane binding 
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N-terminus, and is connected to the F-actin binding C-terminus by a sequence of  ~ 200 
amino acids named the α domain (Fiévet et al, 2007). 
The activity of the ERM proteins is dependent on conformational changes, when 
inactive in the cytoplasm, the N-termini and C-termini show a very strong interaction 
via their N- and C-ERMAD (ERM association domains), effectively masking their own 
F-actin binding site (Gary and Bretscher, 1995). Activation of the ERM proteins is 
thought to be a two-stage process, where binding of the FERM domain with PIP2 
exposes a threonine residue, which is then phosphorylated, leading to ERM activation 
(Fiévet et al, 2004: Hao et al, 2009).  
 
4.1.4.1 A potential model for staurosporine action in cochlear hair cells. 
The antibody we used to detect radixin does not distinguish between the phosphorylated 
and non-phosphorylated forms; therefore an antibody to detect for the presence of phos-
ERM was also used. Cochlear cultures incubated with staurosporine showed a 
noticeable reduction in phos-ERM levels by as early as 1 hour. At 14 hours, there was a 
significant decrease in the amount of phos-ERM but not of radixin in staurosporine 
treated cultures compared to their DMSO controls. Thus it is possible that in hair cells, 
staurosporine prevents activation (phosphorylation) of ERM proteins, resulting in a 
decrease in phosphorylated-ERM proteins, thus leading to the detachment of the apical 
plasma membrane from the cuticular plate (Figure 4.2).  
Our hypothesis that staurosporine affects the function of the ERM proteins as plasma 
membrane-to-cytoskeleton cross-linkers is supported by Yonemura et al (2002), who 
showed that in a range of kidney-derived cell lines, 10 nM staurosporine caused 
inactivation of ERM proteins, redistributing them from the plasma membrane back into 
the cytoplasm. 
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Figure 4.2 A possible mechanism for staurosporine action in hair cells:  prevention of ERM 
protein activation could result in detachment of the plasma membrane from the cuticular plate 
region. 
 
In cochlear hair cells, radixin has been localised to the hair bundle (Pataky et al, 2004: 
Khan et al, 2007), while ezrin was only detected faintly in hair and supporting cells and 
moesin was not detectable in hair cells at P20 (Kitajiri et al, 2004). However, as the 
Western blots carried out for this set of experiments used the entire organ of Corti, both 
phosphorylated ezrin and phosphorylated moesin were present, presumably from all the 
other cell types present in the organ of Corti. Nonetheless, the age of mice used here 
may also have contributed to the phosphorylated ezrin present in the Western blots, as 
Kitajiri et al (2004) showed that ezrin was clearly present in P1 radixin+/+ mice, 
although ezrin staining disappeared by P40. 
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4.1.4.2 Staurosporine inhibition of hair cell ERM proteins is unlikely to involve 
Rho A, B and C. 
Several studies have shown that ERM proteins are activated by a Rho dependent 
pathway in a variety of cell types (Matsui et al, 1999: Haas et al, 2007). If this also 
applied to hair cells, then it would be reasonable to hypothesize that Rho inhibition 
would produce similar hair bundle damage to that seen with staurosporine. In the 
current set of experiments, inhibition of cochlear cultures with the Rho A, B, and C 
inhibitor Clostridium botulinum exoenzyme C3 transferase did not cause direct hair 
bundle damage, but rather an apparent expansion of the luminal surfaces of both hair 
and supporting cells. 
Whether ERM protein activation relies on Rho or not appears to be highly dependent on 
cell type. In the same study in which the effect of staurosporine on ERM protein 
activation was assessed, Yonemura et al (2002) showed a number of cell lines that 
employ a Rho independent pathway for ERM activation. Interestingly, all of these cells 
lines were derived from the kidney. A close association between pathologies of the ear 
and in the kidney has long been noted (Taylor, 1965: Crawfurd and Toghill, 1968), and 
although this was attributed to parallel development times in gestation, is it now known 
that the inner ear and the kidney share many genes that are responsible for essential ion 
channel and transportation proteins (Izzedine et al, 2004: Lang et al, 2007). 
 
Our experiments showed that staurosporine action on hair-cell ERM proteins may not 
involve Rho A, B and C. Other members of the Rho GTPase family however, namely 
Rac and Cdc42, have close associations with ERM activation in other cell types 
(Nakamura et al, 2000: Auvinen et al, 2007) and may well play a part in hair-cell ERM 
protein activation. 
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4.1.4.3 Staurosporine does not affect the distribution of PIP2 in hair bundles. 
Regardless of Rho pathway dependency, an important ERM activation pathway is the 
binding of the FERM domain to PIP2 (Yonemura et al, 2002: Janke et al, 2008). 
Staurosporine could thus inhibit ERM activity by reducing the levels of available PIP2. 
A study using rat basophilic leukaemia cells found that PIP2 production increased with 
PKC activation, but this increase was suppressed by staurosporine-induced PKC 
inhibition, leading to the suggestion that PKC may somehow affect the activity of the 
phospholipid kinases upstream of PIP2 (Apgar, 1995). If staurosporine does decrease 
PIP2 levels in hair cells via PKC inhibition, then it is likely to be acting though PKC 
isoforms other than those inhibited by Myr-LHQRRGAIKQAKVHHVKC-NH2 or 
BIM1 (though the 1 µM BIM1 used in the series of experiments presented here may not 
have inhibited PKCζ, which has an IC50 of 5.8 µM). 
The broad-spectrum nature of staurosporine activity means that it may reduce PIP2 
levels in hair cells by inhibiting phosphoinositide 4-kinase (PI4K) and/or 
phosphoinositide 5-kinase (PI5K), the kinases involved in the PIP2 synthesis, although 
currently there is no published literature to support this. There is a study using 
fibroblasts, however, which suggests staurosporine does not inhibit the phosphoinositide 
kinases, and therefore does not alter the levels of PIP2 (Smith and Mooberry, 1992). In 
the current set of experiments, the PIP2 reporter PLCδ1PH showed PIP2 distribution 
throughout the hair cell as well as the hair bundle in both control and staurosporine 
treated cochlear cultures, indicating that staurosporine probably does not affect PIP2 
distribution or levels in hair cells and hair bundles.  
While there is agreement in the literature that activation of ERM requires binding to 
PIP2 (Louvet-Vallée, 2000: Fiévet et al, 2007), there is less agreement on whether 
subsequent phosphorylation of ERM proteins is needed to either complete the activation 
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process, or to simply maintain the ERM proteins in an activated form (Yonemura et al, 
2002). In both cases, phosphorylation remains essential to the proper function of ERM 
proteins, and staurosporine has been shown to inhibit two known ERM kinases, 
myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) and lymphocyte-
oriented kinase (LOK), at nanomolar concentrations (Nakamura et al, 2000: Belkina et 
al, 2009: Nakano and Ōmura, 2009). 
 
4.1.4.4 Staurosporine also causes loss of microvilli in supporting cells. 
Early studies isolated ERM proteins from the brush border of chicken intestinal 
epithelial cells as well as microvilli of human carcinoma cells (Bretscher, 1983: 
Pakkanen et al, 1987). Since then, much work has been done on the essential role of 
ERM proteins in microvilli formation in a wide variety of cell types (Saotome et al, 
2004: Bonilha et al, 2006: Lan et al, 2006). In our SEM images of basal region cochlear 
supporting cells, there is a distinct paucity of microvilli on their apical surfaces 
compared to controls after 14 hours of staurosporine treatment. This loss of microvilli 
may be due to the staurosporine-induced loss of ERM function in supporting cells, as 
antibody staining showed a clear decrease in levels of phos-ERM in microvilli of 
staurosporine treated supporting cells compared to controls.  
 
4.2 Hair bundle recovery from staurosporine or neomycin treatment. 
4.2.1 Hair bundles do not recover from staurosporine or neomycin treatment. 
Previous studies have shown that hair cell loss is followed by hair cell regeneration in 
many species including fishes (Hernández et al, 2007), amphibians (Jones and Corwin, 
1996) and birds (Corwin and Cotanche, 1988). Nevertheless, the fate of damaged hair 
bundles on hair cells that survive trauma is less clear, where tip links of P1 chick hair 
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bundles were lost due to noise exposure, they recovered to control numbers in 
approximately 3 days (Husbands et al, 1999: Kurian et al, 2003) while horizontal top 
connectors of chinchilla hair bundles have been shown to recover from noise trauma in 
14-28 days (Tsuprun et al, 2003). However, the recoveries of tip links and horizontal 
top connectors shown by the studies referred to above appear to take place in hair 
bundles that retained good cohesion. Where the hair bundles of P10 chicks had 
degenerated into separate upright clumps due to noise damage, no hair bundle repair 
was observed after the 10-day recovery period (Cotanche, 1987b). If hair bundle 
recovery were dependent on the severity of disruption, then the complete hair bundle 
collapse caused by staurosporine would be unlikely to result in recovery.  
 
While hair bundle collapse characterises the external morphological effect of 
staurosporine on cochlear hair cells in our experiments, the initial external 
morphological effect of neomycin manifests as blebbing on the hair cell apical surface. 
Neomycin is a member of the class of aminoglycoside antibiotics, which are known to 
cause apoptosis by either generation of reactive oxygen species (Clerici et al, 1996: 
Lopez-Gonzalez et al, 1999) or by caspase activation (Cunningham et al, 2002: Taylor 
et al, 2008). Goodyear et al (2008) showed that hair cells could recover from blebbing 
caused by 5 or 30 minutes of neomycin treatment at 20 °C following a 2-hour recovery 
period. Furthermore, Goodyear et al (2008) showed that hair cells treated with 
neomycin for 30 minutes could survive for at least a further 24 hours with no additional 
detrimental effects on the hair bundles (Goodyear et al, 2008. Supplemental material: 
Figure 3, available at www.jneurosci.org). Yet the time window in which hair cells can 
recover from neomycin treatment appears to be narrow, the current set of experiments 
showed that after 60 minutes of neomycin treatment at 20 °C with 23 hours of recovery 
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time at 37 °C, blebbing was much reduced, but the hair bundles were showing signs of 
disruption. Longer neomycin treatment of 2 and 4 hours resulted in severe OHC hair 
bundle damage and OHCs being extruded. 
 
4.2.2 Staurosporine and neomycin causes hair bundle degeneration after cessation 
of treatment. 
The series of experiments presented here showed that hair bundle damage and collapse 
caused by either staurosporine or neomycin was not reparable. We also showed that 
even after cessation of treatment, staurosporine and neomycin caused hair bundle 
degeneration, even where there was no hair bundle damage when treatment ended. This 
phenomenon is in line with a previous study that showed undamaged chick hair cells at 
the cessation of noise trauma going on to develop damaged stereocilia within 24 hours 
(Cotanche, 1987b). 
In the brief 2.5-hour treatment period used in this study, staurosporine must be 
adversely affecting one or more essential processes in hair bundle maintenance. Since 
these processes do not recover from this short treatment time, it may be possible that 
staurosporine is affecting longer-term gene expression, which under normal 
circumstances would contribute to maintaining the hair bundle. Staurosporine has been 
shown to affect gene expression in other cell types from expression of the neuropeptides 
neurotensin and neuromedin in pheochromocytoma cells (Tischler et al, 1991), and 
transcription of an insulin gene promoter in pancreatic cells (Shinozuka et al, 2003) to 
gene expression for important matrix proteins in fibrochondrocytes (Hoben and 
Athanasiou, 2008). Performing a microarray analysis of hair cells treated with 
staurosporine or DMSO as a control will help to clarify this issue. 
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In the case of neomycin, our results showed that 10 µM neomycin over 3 days does not 
produce visible hair bundle damage, however, a further 3 days in neomycin-free media 
resulted in loss of all OHC hair bundles. This loss of OHC hair bundles may result from 
the loss of the OHCs themselves, and this is supported by the loading of propidium 
iodide by OHCs seen after 3 days of neomycin incubation indicating that the OHCs 
were already fatally compromised. This experiment will need to be repeated to confirm 
these findings, but it will be exciting to further explore the mechanism of neomycin 
action in auditory hair cells. 
 
4.3 JNK inhibitor I 
4.3.1 Different JNK inhibitors have been used in different hair cell studies. 
The JNK inhibitor I used in this series of experiments was the L-stereoisomer of the 
small peptide inhibitor engineered by Bonny et al (2001): L-JNKI-I. This inhibitor was 
created from islet-brain proteins (also known as JNK-interacting proteins [JIPs]), which 
are scaffold proteins that are mainly expressed in the pancreatic islets and in the brain. 
L-JNKI-I was created by linking a minimal 20–amino acid sequence of the islet-brain 
JNK binding domain (the minimal sequence needed to block c-Jun activation) to the 
10–amino acid HIV-TAT sequence that allows rapid cell permeability. The authors also 
created a D-stereoisomer (D-JNKI-I) by the retro-inverso method: biologically active 
peptides normally consist of only L-amino acids (Stryer, 1995), but since these are 
highly susceptible to proteases (Brugidou et al, 1995), a method was developed 
whereby L-amino acid residues are replaced by the corresponding D-amino acids and 
the peptide sequence is reversed, resulting in a “retro-inverso”, more stable, D- 
stereoisomer (Hervé et al, 1997). Both L-JNKI-I and D-JNKI-I isoforms were found to 
block phosphorylation (activation) of c-Jun in the murine insulinoma cell line βTC-3, 
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although D-JNKI-I was 15-20 fold less effective than L-JNKI-I (Bonny et al, 2001). 
However, D-JNKI-I showed greater intracellular stability, and was able to prevent pro-
inflammatory cytokine interleukin- (IL-1β) induced apoptosis for up to two weeks after 
just a single application compared to two days for L-JNKI-I (Bonny et al, 2001). 
Another JNK inhibitor commonly used in hair cell studies is CEP 1347 (previously 
known as KT 7515), a semi-synthetic derivative of the indolocarbazole K-252a found in 
broths of Narcodiopsis bacterium (Maroney et al, 1998: Bogoyevitch et al, 2004). CEP 
1347 inhibits the kinase activity of the mixed lineage kinase (MLK) family, members of 
the MAPKK kinases (Figure 4.3), thus preventing JNK activation. Previous in vivo and 
in vitro studies have shown that inhibition of JNK by either D-JNKI-1 (Wang et al, 
2003: Wang et al, 2007: Coleman et al, 2007: Eshraghi et al, 2007) or CEP 1347 
(Pirvola et al, 2000) protects mammalian auditory hair cells from the effects of 
aminoglycoside or noise damage. 
 
 
Figure 4.3 CEP 1347 prevents JNK activation by inhibition of upstream mixed lineage kinases. 
 - 97 - 
4.3.2 JNK inhibitor I caused hair bundle damage and hair cell loss.  
Of the JNK inhibitors used in this set of experiments, a search of the literature shows 
that neither JNK inhibitor V nor JNK inhibitor II (also known as SP600125) had been 
used previously in hair cell studies. However, in the light of studies showing JNK 
inhibitors conferring otoprotection, ototoxicity was not especially anticipated from the 
three JNK inhibitors (JNK inhibitors I, II and V) used in the current protein kinase 
screen. However, our experiments with L-JNKI-I unexpectedly resulted in elongation 
and collapse of both apical and basal region IHC stereocilia, with disrupted OHC hair 
bundles in the apical region, whilst OHC hair bundles were missing in the basal region, 
demonstrating a base to apex gradient in effect. This gradient is reflected in 
transmission electron micrographs as early as 5 hours after L-JNKI-I treatment, with 
basal region OHC hair bundles more severely disrupted than their apical region 
counterparts. Indeed, phosphatidylserine externalization could be detected in L-JNKI-I 
treated cultures as early as 5 minutes after onset the of treatment, suggesting that L-
JNKI-I has a rapid effect on phospholipids, possibly as a first step in causing hair cells 
to undergo apoptosis. Neither JNK inhibitor II nor V had any detrimental effect when 
tested on cochlear cultures for 24 hours.  
In other cell types, it is known that JNK inhibitor II prevents T-helper cell apoptosis as 
well as having anti-inflammatory actions (Bennett et al, 2001), while JNK inhibitor V 
protects cardiomyocytes and axons from apoptosis in response to ischaemia (Ferrandi et 
al, 2004: Carboni et al, 2008). 
 
4.3.2.1 Possible methodological differences between studies. 
Could differences in methodology account for the ototoxicity seen in our experiments as 
opposed to the otoprotection shown in other studies? In vitro experiments with either D-
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JNKI-I (Wang et al, 2003) or CEP 1347 (Pirvola et al, 2000) used cultures from P3 
mice or P2 rats respectively, which were similar in age to the P2 mice used in our set of 
experiments. The incubation times of 24-48 hours are also similar to those used in the 
current set of experiments, hence in terms of methodology, it is unlikely that differences 
in species or incubation times would have caused such a discrepancy between this study 
and others. 
The concentration of 2 µM D-JNKI-I used by Wang et al (2003) was lower than the 5 
µM L-JNKI-I used here, thus perhaps the higher concentration of JNK inhibitor used in 
our set of experiments may have caused hair bundle collapse and subsequent basal OHC 
loss. In a study of cortical neurons, Repici et al (2009) used 2 and 4 µM D-JNKI-I for in 
vitro experiments, but were unable to apply the higher concentration of 10 µM which 
they had used for their cell free conditions due to “toxic effects”, although the type and 
extent of the toxic effects were not stated. Bonny et al (2001) themselves used 25 µM L-
JNKI-I to demonstrate suppression of c-Jun phosphorylation in the βTC-3 cell line, with 
no cell toxicity reported. However, the experiments presented here show that a 
concentration of 2 µM L-JNKI-I was sufficient to induce phosphatidylserine 
externalization, therefore it appears unlikely that a concentration difference between 
studies is the sole source of L-JNKI-I toxicity. 
In terms of experimental design, previous experiments used D-JNKI-I in conjunction 
with other conditions such as noise (Coleman et al, 2007: Wang et al, 2007) or 
neomycin (Wang et al, 2003: Eshraghi et al, 2007). Although βTC-3 cells (Bonny et al, 
2001) and cortical neurons (Repici et al, 2009) have been treated solely with D-JNKI-I 
under physiological conditions with no resultant cell death at up to a concentration of 25 
µM (Bonny et al, 2001), this has yet to be carried out with D-JNKI-I in cochlear 
cultures. 
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4.3.2.2 Possible JNK inhibitor I isoform differences between studies 
In both in vivo and in vitro studies of hair cells (Wang et al, 2003: Wang et al, 2004: 
Coleman et al, 2007: Eshraghi et al, 2007: Wang et al, 2007) as well as in a variety of 
other cell types (Hirt et al, 2004: Colombo et al, 2009), D-JNKI-I has been the JNK 
inhibitor I of choice over L-JNKI-I, in all probability for its greater intracellular 
stability. Stereoisomers are designated L or D according to their spatial arrangement as 
well as “+” or “-” according to their optical properties, and both structural and optical 
stereoisomers of the same compounds/drugs have been known to have different efficacy 
and toxic effects in a wide variety of drug groups (Stoschitzky et al, 1998: Smith, 2009). 
In the cochlea, this phenomenon has been documented for the loop diuretic indacrinone, 
where (+) indacrinone causes a dose dependent reduction in both the endocochlear 
potential and the compound action potential in chinchillas, while (-) indacrinone caused 
little or no change (Rybak et al, 1987: Rybak et al, 1991). In addition, the L-
stereoisomer of the anti-cancer agent difluoromethylornithine (DFMO) has been 
demonstrated to significantly decrease the endocochlear potential and the compound 
action potential compared to D-DFMO in guinea pigs (McWilliams et al, 2000).  
Although Bonny et al (2001) showed that both L and D isoforms of JNKI-I inhibit 
phosphorylation of c-Jun in βTC-3 cells with no cell damage, another study showed that 
in a different murine insulinoma cell line, NIT-1, D-JNKI-I causes necrosis while L-
JNKI-I prevents IL-1β-induced apoptosis by inhibition of c-Jun phosphorylation 
(Fornoni et al, 2007). 
 
4.4 Summary of future directions 
1) Although the fluorescence data from the current set of experiments suggest that 
staurosporine acts through inhibition of ERM protein phosphorylation, the 
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immunoblotting data that support this are derived from lysates obtained from the entire 
organ of Corti. In order to evaluate radixin and phos-ERM levels specifically in hair and 
supporting cells, separation of these cell types from the organ of Corti prior to 
immunoblotting would be necessary. This could be carried out by fluorescence-
activated cell sorting (FACS) using antibodies against a hair cell marker such as Ptprq 
and p27Kip1 for supporting cells. 
 
2) It may be that in addition to causing hair bundle collapse, inhibition of phos-ERM 
function by staurosporine also prevents hair bundle recovery. It would therefore be 
informative to ascertain whether phos-ERM levels return to pre-treatment levels after 
cessation of staurosporine treatment.  
 
3) The degeneration of hair bundles after the cessation of a brief period of staurosporine 
treatment suggests that staurosporine may affect gene expression that regulates hair 
bundle maintenance. Microarray analysis of hair cells treated with staurosporine could 
be carried out to investigate this possibility, 
 
4) Early work suggested that JNK inhibitors may have a role in otoprotection against 
insults such as noise or aminoglycosides, but the JNK inhibitor used in the current 
experiments proved toxic to hair cells. Therefore, in order to clarify the potentially 
different effects of L-JNKI-I and D-JNKI-I on hair cells, it is important that experiments 
are carried out to assess cochlear cultures after treatment with these two stereoisomers 
at different concentrations over different times points.  
 
 
 - 101 - 
4.5 Conclusions 
Although staurosporine has been more conventionally used in studies to induce 
apoptosis, its use at low doses in our set of experiments revealed a vital role for protein 
phosphorylation in maintaining the integrity of the hair bundle. The attachment of the 
hair-cell apical membrane to the cuticular plate, as well as hair bundle morphology, are 
both disrupted by staurosporine treatment. The detachment of the hair-cell apical 
membrane may be caused by staurosporine inhibition of ERM protein phosphorylation, 
and further experiments are needed to confirm this.  
We showed that staurosporine is not toxic to hair cells, but hair cells are unable to 
maintain or repair their hair bundles even after brief staurosporine treatment, indicating 
that staurosporine, in addition to inhibiting phos-ERM phosphorylation, may affect gene 
expression. All of the protein kinases that were inhibited in the initial screen are known 
to influence actin regulation in a variety of cell types. Despite this, inhibiting many of 
these protein kinases had either no effect on hair bundles or was lethal to hair cells, 
demonstrating that there is much yet to be learnt about the role of protein kinases in hair 
cell and hair-bundle maintenance. The inability of mammalian auditory hair cells to 
regenerate after trauma has led to the investigation of compounds that may confer 
otoprotection from both acoustic and pharmacological insults that would otherwise 
cause hair cells to undergo apoptosis. The JNK inhibitors D-JNKI-I and CEP1347 have 
been shown by several groups to achieve this. However, the use of L-JNKI-I in this set 
of experiments has shown for the first time that this compound is toxic to cochlear hair 
cells. Further investigation will confirm whether all JNK inhibitors exhibit otoprotective 
effects under the same experimental conditions, or whether otoprotection is confined to 
specific JNK inhibitors, a vital distinction if JNK inhibitors are to be considered for 
future clinical application. 
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